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ABSTRACT 
Hypersensitivity Pneumonitis (HP) is an interstitial lung disease caused by 
repeated inhalation of a wide range of environmental antigens. It is characterized by 
alveolitis, granuloma formation, and fibrosis. Since HP is a T cell-mediated disease, it is 
important to determine the type of T cell response associated with granuloma formation 
and the factors that control this response. We hypothesized that HP is associated with a 
predominant Th17 cell response where both T-bet and TLRs 2 and 9 are controlling T 
cell response during HP. The results demonstrated a predominant Th17 response 
associated with granuloma formation in the lungs of C57BL/6J mice during 
granulomatous and chronic HP. We also found that T-bet KO mice exposed to 
Saccharopolyspora rectivirgula (SR) were characterized by exacerbated Th17 cell 
response accompanied by an increase in granuloma formation and collagen production in 
the lungs compared to WT exposed mice. In an attempt to find other factors regulating 
Th17 development, previous studies in our lab showed that TLR2/9 double knockout 
(DKO) exposed mice were characterized by a decrease in the percentage of Th17 cells in 
their lungs compared to WT mice. Consequently, we hypothesized that the decrease in 
Th17 response is attributed to defect in phagocytosis, or cytokines production, or antigen 
presentation ability of TLR2/9 DKO antigen presenting cells (APCs). In vitro, we found 
no significant difference in the phagocytosis ability of both WT and TLR2/9 DKO 
BMDMs (Bone Marrow Derived Macrophages) or BMDCs (Bone Marrow Derived 
Dendritic Cells). In vivo, there was no significant difference in the phagocytosis ability of 
both WT and TLR2/9 DKO alveolar macrophages. Although we found that both TLRs 2 
and 9 were regulating cytokine production e.g. IL-6, IL-10, and TNF? from BMDMs, we 
did not find a defect in antigen presentation ability of both WT and TLR2/9 DKO splenic 
APCs. In conclusion, these findings suggested the following: (1) Both granulomatous and 
chronic HP is associated with a predominant Th17 response and granuloma formation; 
(2) T-bet plays a role in controlling disease severity and Th17 development during HP; 
(3) TLR2 and 9 do not affect APCs’ ability to phagocytose SR but they affect cytokine 
production; and (4) Both WT and TLR2/9 DKO APCs are equally efficient in presenting 
SR antigen to T cells.  
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CHAPTER 1.   INTRODUCTION 
Hypersensitivity Pneumonitis (HP) is an interstitial lung disease caused by 
repeated inhalation of a wide range of environmental antigens. Alveolitis, granuloma 
formation, and fibrosis are the hallmarks of the disease. Fibrosis is irreversible and 
associated with significant morbidity and mortality. To date, the only available treatments 
are corticosteroids and avoiding environmental antigen, and as such it is crucial to 
understand the immunopathogenic mechanisms underlying the disease, which may lead 
to development of novel therapies. Since several studies showed that HP is a 
T cell-mediated disease, the main goals of our studies were as follows:   
1- Investigate the T cell response (Th1 or Th17) during HP  
2- Investigate the effect of T-bet (T helper 1 cell transcription factor) on 
T cell response and disease severity during HP  
3- Determine whether TLRs 2 and 9 in antigen presenting cells contribute 
to the Th1 or Th17 response during HP  
TYPES OF HYPERSENSITIVITY REACTIONS 
During our daily life, we are exposed to a wide range of antigens from different 
sources. The main function of our immune system is to deal with them in an appropriate 
way without damaging the host. For example, infectious agents such as bacteria, viruses, 
fungi, and parasites should be cleared efficiently by our immune system; while innocuous 
agents such as pollen grains and foods should not induce an immune response. However, 
in some circumstances a host will develop an exaggerated immune response against an 
inciting agent and it is the immune response that causes pathology. Therefore, the patient 
is hypersensitive against an inciting agent by developing hypersensitivity reaction. 
Hypersensitivity reactions are mediated by both arms of adaptive immunity, i.e.  humoral 
immunity (antibody mediated) and cellular immunity (cell mediated). According to Gell 
and Coombs, hypersensitivity reactions are classified into four types: Type I (immediate 
hypersensitivity), II (cytotoxic hypersensitivity), III (immune complex mediated 
hypersensitivity), and IV (delayed or cell-mediated hypersensitivity) [1]. Type I 
Hypersensitivity is mediated by IgE antibodies, where hay fever or allergic asthma are 
considered as the classic examples of this type of hypersensitivty. Type I Hypersensitivy 
is initiated by activation of Th2 cells by allergens resulting in IgE production. IgE 
antibodies bind to mast cells, sensitizing them to subsequent exposures. With subsequent 
exposures, allergens bind to IgE on surface of mast cells causing degranulation of mast 
cells and the release of histamines causing contraction of smooth muscles, vasodilatation, 
and, increase in vascular permeability [2].  
Type II hypersensitivity is mediated by IgG and IgM antibodies directed towards 
target antigens on the cell surface. These antibodies bind to their antigens on cells and are 
recognized by macrophages via their Fc receptors resulting in killing or cytolysis through 
complement activation. Hemolytic anemia (destruction of RBCs) and thrombocytopenia 
2 
(destruction of platelets) are the most common examples of type II hypersensitivity. Type 
III hypersensitivity develops in sensitized individuals who have IgG directed against a 
specific antigen. Upon subsequent exposure to the antigen the individual forms antibody-
antigen immune complexes which get deposited in the tissues. Normally, large immune 
complexes are cleared by phagocytes; however small immune complexes, such as those 
that occur in type III are not phagocytosed and tend to deposit in blood vessels causing 
tissue damage [2]. Type IV hypersensitivity is not mediated by antibodies as the previous 
types; instead it is cell-mediated. The specific antigen is presented by antigen presenting 
cells (APCs) to effector T cells, thereby stimulating cytokine release. The example of this 
type is granulomatous inflammation which will be discussed in detail later on in this 
chapter. The Tuberculin test is the most common example that exemplifies the sequence 
of cellular events in Type IV Hypersensitivity. Intradermal injection of tuberculin 
(carbohydrates and peptides from M. tuberculosis) elicits a T cell-mediated inflammatory 
response caused by Th1 cells. Th1 cells secrete IFN? and TNF? once they recognize the 
antigen presented by APCs. These cytokines enhance expression of adhesion molecules 
on the endothelium and increase vascular leakiness resulting in recruitment of plasma 
cells and accessory cells [1]. Hypersensitivity Pneumonitis (HP) is classified under both 
type III and type IV hypersensitivity [3, 4] for several reasons that will be discussed in 
detail later in this chapter. 
 
 
NAÏVE CD4+ T CELL DIFFERENTIATION 
 
There are two types of immune response: innate (early) and adaptive (late) 
immune response. Adaptive immunity is further classified into cell-mediated (T cells) 
and humoral (antibodies secreted by B cells). T cells are divided into CD4+ T cells 
(Helper T cells) and CD8+ T (Cytotoxic T cells) (Fig. 1-1). The term helper stems from 
these T cells’ ability to help B cells for antibody class switching and activation of 
macrophages. CD8+ T cells are called cytotoxic T cells since they directly kill host cells 
infected with intracellular microorganisms by secretion of perforins and granzymes.  
 
Once T cells are generated in the thymus (primary lymphoid organ), they exit to 
the circulation as naïve T cells. Naïve CD4+ T cells have not yet encountered a foreign 
antigen in their life cycle and they continuously circulate between blood and lymph nodes 
(secondary lymphoid organs). If they encounter a foreign antigen in the lymph node, they 
will become activated and differentiate into an effector CD4+ T cell. A naïve T cell only 
encounters an antigen if it is presented by dendritic cells (DCs) in the lymph node. DCs 
function to capture foreign antigens at the site of infection, process the antigen forming a 
complex between the peptide and Major histocompatibility complex molecule class II 
(MHCII) molecules then migrate to the draining lymph nodes to present the  
antigen/MHC II complex to naïve CD4+ T cells [5]. During presentation, DCs provide 
three signals to naïve T cells; signal 1 is processed antigen /MHC II complex engaging 
antigen specific T cell receptor (TCR). Signal 2 is engagement of costimulatory 
molecules; e.g. CD80 and CD86 by CD28 on the T cell [6] resulting in upregulation of 
IL-2 production and hence T cell proliferation [7]. Signal 3 is cytokine stimulation that 
directs naïve CD4+ T cells to differentiate into effector Th1, Th2, Th17, or iTregs cells  
3 
Figure 1-1. Types of immune response. 
The immune response is divided into innate and adaptive immunity. Adaptive immunity 
is further classified into cell-mediated and humoral immunity. Finally, both CD4+ and 
CD8+ T cells are classified under cell-mediated immunity.  
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(Fig. 1-2). In summary, the culmination of 3 signals leads to differentiation of naïve 
T cells into effector T cells. 
 
Each major subset of Th cells requires different cytokines and transcription 
factors to regulate their differentiation. For Th1 cell differentiation, the master 
transcription factor T-box expressed in T-cells (T-bet) is required for differentiation and 
induction of IFN?? ???. Although the Th1 response is protective against intracellular 
pathogens, excessive uncontrolled Th1 response leads to tissue inflammation and 
autoimmune diseases. Although the name suggests that T-bet is only expressed in T cells, 
other immune cells such as Dendritic cells [9], NK, and NKT cells [10] can also express 
T-bet. During presentation to a naïve CD4 helper T cell, T-bet is induced by the 
synergistic effect of T cell receptor engagement and IFN?-STAT1 signaling. Induction of 
T-bet expression stimulates expression of IFN? and IL-12 receptor inducible chain 
(IL-12R?2) which makes the T cells responsive to IL-12 and induces another wave of 
T-bet expression stabilizing Th1 lineage [11-13]. The master transcription factor for Th2 
cells is GATA3 which is induced by IL-4. The Th2 signature cytokines are IL-4, IL-5, 
and IL-13 which are required for eosinophil recruitment and IgG and IgE class switching. 
Th2 responses are important for extracellular pathogens and parasite clearance. IL-13 is 
involved in mucosal activation (mucus hypersecretion), and therefore an excessive Th2 
response is associated with asthma [14]. 
 
The master transcription factor(s) for Th17 effector T cells are Retinoid-related 
Orphan Receptor (ROR) ?t and ROR?. The combination of proinflammatory cytokine 
IL-6 with immunoregulatory cytokine TGF? stimulates Th17 cell differentiation in mice 
[15-18]. IL-6 and TGF? cooperate in induction of ROR?t which is required for IL-17A 
and IL-17F mRNA expression [19]. The signature cytokine for Th17 cells is IL-17 which 
comes in several isoforms (IL-17A-IL-17F). In addition to IL-17, Th17 cells also secrete 
IL-21 and IL-22 which are important in the overall Th17 response to pathogens [19-22]. 
Several studies demonstrated the protective role of Th17 effector cytokines in 
extracellular and intracellular bacterial and fungal infections [23-28]. For instance, 
IL-17A and IL-17 receptor Knockout mice are prone to K. pneumoniae infection [27, 28]. 
Furthermore, Th17 cells are also protective in Mycobacterium tuberculosis infections 
indirectly, and IL-17 induces chemokines required for recruitment of protective Th1cells 
[24]. Also, in F. tularensis live vaccine infection model, IL-17 induces IL-12 from 
dendritic cells to establish a Th1 response and induces IL-12 and IFN? from macrophages 
to enhance bacterial killing [29]. Additionally, in acute respiratory tract infection caused 
by Mycoplasma pneumoniae IL-17A and IL-17F derived from Th17 cells are important 
in induction of lung neutrophil infiltration for pathogen clearance [25]. IL-22 also plays a 
protective role in K. pneumonia and C. rodentium mouse infection model [28, 30]. In 
K. pneumonia mouse infection model, neutralization of IL-22 increases the mortality rate 
compared to WT mice. Also, mice treated with anti-IL-22 had a significant increase in 
lung and spleen CFUs compared to WT mice [28]. Similarly, IL-22 KO mice infected 
with C. rodentium are characterized by a significant decrease in survival rate compared to 
WT mice [30]. In fungal infections, IL-17R A knockout mice are prone to Candida
albicans infection compared to their wild-type counterparts and the injection of IL-17A 
into knockout mice protected them from lethal doses of infection [23]. Although Th17  
5 
Figure 1-2. Differentiation of naïve T cell to different subsets of effector CD4+ T 
cells.  
 
Naïve CD4+ T cells require three signals to differentiate into effector CD4+ helper T cells. 
Signals 1 and 2 come from T cell receptor and costimulatory receptors signaling. The 
nature of the cytokine environment (signal 3) determines the fate of naïve CD4+ T cells. 
IFN? and IL-12 are required for Th1 differentiation, while IL-4 is required for Th2 
differentiation. The combination of IL-6 and TGF? are required for Th17 cell 
differentiation while TGF? is required for differentiation of naïve T cells to iTregs 
(induced Tregs). Each subset of effector T helper cells has its own specific transcription 
factor. T-bet, GATA3, ROR?t and ROR??and Foxp3 are?specific for Th1, Th2, Th17 and 
iTregs respectively. The effector CD4+ T cells are characterized by their signature 
cytokines. IFN? is the hall mark cytokine for Th1 cells while IL-4, 5, and 13 are specific 
for Th2. IL-17A, IL-17F, IL-21, and IL-22 are specific for Th17. (Adapted with 
permission from Bettelli, E., et al., Induction and effector functions of T(H)17 cells. 
Nature, 2008. 453(7198): p. 1051-7 [31].) 
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cells and cytokines play a protective role against numerous infections, several studies 
demonstrated their pathogenicity as inducers of tissue inflammation in a number of 
organ-specific autoimmune diseases such as Rheumatoid Arthritis, Multiple Sclerosis, 
and inflammatory bowel disease [32-38]. In conclusion, Th17 cytokines protect against a 
wide range of bacterial and fungal infections; however, Th17 cells can also play a 
pathogenic role in certain circumstances. 
Regulatory T cells (Tregs) play a crucial role in maintaining immunological 
homeostasis and suppressing immune response. They are divided into two subsets, 
Natural Tregs (nTregs) that develop in the thymus and induced Tregs (iTregs) derived 
from peripheral naïve CD4+ T cells under the effect of TGF? and IL-2. Foxp3 is the 
master transcription factor for Tregs and it is required for their suppressive function. Both 
cytokines (IL-2 and TGF?) are required for maintenance of Foxp3 in Tregs and iTregs. 
Mutations in Foxp3 causes a rare autoimmune disease IPEX (Immune-dysregulation 
Polyendocrinopathy Enteropathy X-linked) in humans characterized by a variety of 
inflammatory lesions in different tissues with massive production of Th1 and Th2 
cytokines. Tregs use IL-2Ra (CD25) as a receptor for IL-2. Although they don’t produce 
IL-2, they require IL-2 for their survival and expansion. They inhibit effector function of 
T cells through several mechanisms, e.g., suppression by cytokines, cytolysis, metabolic 
disruption, and targeting dendritic cells [14, 39-41]. 
 
 
GRANULOMA FORMATION  
 
 
Definition  
 
A granuloma is an organized mass of immune cells that mainly consists of 
macrophages, dendritic cells, B cells, and T cells. Even though a granuloma is an 
organized structure of cells, it is a dynamic microenvironment where immune cells are 
recruited to or egressing from the granuloma under the influence of chemokines and 
adhesion molecules. In addition, there is also cross-talk between the cells in the 
granuloma resulting in activation of cells and cytokine secretion. The main function of a 
granuloma is to wall-off the inciting agent from the surrounding tissue; however, if the 
microorganism is persistent and the granulomas do not resolve, tissue damage and 
eventually fibrosis occur giving granuloma characteristic of a double-edged 
sword [42-44]. 
 
 
Requirements 
 
Although granuloma consists of different types of immune cells, several studies 
demonstrated the pivotal role of T cells in granuloma formation. RAG KO mice (mice 
deficient in T and B cells) were unable to form liver granulomas around schistosome ova 
and were unable to control bacterial dissemination or growth after mycobacterium 
infection. Furthermore, adoptive transfer of CD4+ T cells into RAG KO mice infected 
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with Schistosoma or mycobacterium causes granuloma formation [45]. Several studies 
have shown the crucial role of CD4+ T cells in granuloma formation. HIV patients 
(patients with low CD4 T cells counts) are vulnerable to intracellular pathogens that 
require granuloma formation, such as M. tuberculosis, H. capsulatum, and Pneumocystis
carinii [46]. In the Tubercule bacilli (TB) mouse infection model, depletion of CD4+ T 
cells leads to disorganized granuloma that results in reactivation and dissemination of 
tuberculosis [47]. In the same line of evidence, mice lacking functional CD4+  T cells are 
rendered susceptible to listeria infections which require granuloma for protection [48]. 
Additionally, depletion of CD4+ T cells in mice infected with Schistosoma mansoni 
developed smaller granulomas and less fibrosis [49]. Intuitively, the repertoire of T cells 
in the granuloma should be specific only to the antigen found at the site of inflammation; 
however, there are a percentage of non-specific T cells recruited into the granuloma. For 
example, in a S. mansoni mouse infection model, infection with LCMV (Lymphocytic 
Choriomeningitis Virus) causes recruitment of LCMV-specific CD8+ T cells into 
S. mansoni egg granuloma [50]. In summary, these studies have shown the importance of 
T cells specifically CD4+ T cells in granuloma formation. 
Cytokines and chemokines are also considered important requirements for 
granuloma formation. Using a TB mouse infection model, several studies have shown the 
importance of TNF? and IFN? in the process of granuloma formation. The absence of 
TNF? signaling causes a decrease in the number and size of granulomas [51, 52]. Also, 
there is an increase in the mortality of TNF? KO infected mice compared to WT infected 
mice [53]. Also, IFN? KO mice fail to form granulomas following M. tuberculosis 
infection [54]. In conclusion, both TNF? and IFN? are important cytokines for 
granuloma formation. It difficult to distinguish the role of TNF? whether in the initiation 
or maintenance of granuloma since tissues were harvested at different time points 
following TB infection. To get around this limitation, Clay et al. used an intravital 
imaging system to track Mycobacterium marinum infected macrophages in zebra fish 
embryos deficient in TNF? signaling [55]. The authors found normal recruitment of 
macrophages to the site of infection in both WT and TNF? deficient zebra fish embryos 
suggesting that TNF? is dispensable for granuloma formation. The next crucial 
experiment was to determine if TNF is important for granuloma maintenance. Studies 
using a chronic TB mouse infection model showed that neutralization of TNF? leads to 
inability to maintain granuloma in the lungs [56, 57]. Furthermore, intravital imaging was 
used in mice exposed to Mycobacterium bovis BCG. TNF? neutralization caused a 
decrease in the size of granulomas since the trafficking of uninfected macrophages was 
reduced [58]. In conclusion, TNF? plays a crucial role in granuloma maintenance, but 
how does TNF? regulate granuloma maintenance? In one study, in vitro and in vivo 
neutralization of TNF? downregulated chemokines secreted from macrophages and other 
myeloid cells that may affect cell migration in and out of granuloma [56]. In conclusion, 
both TNF? and IFN? are important cytokines for granuloma formation.  
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Granuloma as a Dynamic Environment  
As mentioned before, granulomas are dynamic microenvironments where there 
are immune cells infiltrating and egressing the granuloma. The number of cells in the 
granuloma is determined by many factors. The balance between egression and infiltration 
of immune cells is one and survival time, proliferation, and death of the immune cells are 
other factors [42]. There are controversies regarding the role of TNF? in regulation of 
cell death. Several studies showed that blockage of TNF? in murine models caused 
macrophage apoptosis and major histopathological changes in the lung [52, 59]. In 
contrast,  in vitro TNF? induces apoptosis of human alveolar macrophages infected with 
M. tuberculosis [60]. Using the Zebrafish M. muranium infection model, there was an 
increase in granuloma non-apoptotic cell death in the absence of TNF signaling [55]. In 
conclusion, TNF? plays a controversial role in regulation of cell death in granuloma.  
 
The interaction between T cells and antigen presenting cells (APCs) is another 
process that dictates the microenvironment in the granuloma. For example, DCs with 
high expression of costimulatory molecules, MHCII and secretion of IL-12 were able to 
induce IFN? from Th1 cells which ultimately stimulates macrophages to kill TB, while 
IL-10 secreting DCs with low costimulatory and MHCII  expression were not able to 
induce IFN? from T cells supporting TB persistence within macrophages [44]. In 
conclusion, the combination of several processes are required for granuloma formation; 
the balance between egression and recruitment of cells, cytokines and chemokines, 
survival of the cells within granuloma, and finally the cross-talk between the cells in the 
granuloma. 
 
 
Fate of Granuloma  
 
The fate of a granuloma may be resolution by apoptosis or alternatively a failure 
to resolve which may lead to fibrosis. Fibrosis is an uncontrolled wound repair process in 
which damaged tissue is replaced by a fibrotic scar that ultimately impairs organ 
function. The process is characterized by excessive production and accumulation of 
extracellular matrix (ECM) proteins (e.g. collagen, proteoglycans, and fibronectins) from 
myofibroblasts. It is a complex process that includes immune cells (T cells, macrophages, 
and neutrophils), non-immune cells (epithelial cells, fibroblasts, myofibroblasts, and 
fibrocytes), and proinflammatory and profibrotic mediators. TGF??is one of the 
profibrotic cytokines that plays a central role in fibrosis, it induces fibroblast proliferation 
and activation, production of ECM from myofibroblasts, and epithelial-mesenchymal 
transition process (EMT), a process in which epithelial cells transform into fibroblast-like 
cells [61]. Using bleomycin and farmer’s lung models, studies have shown that IL-17A, 
and IL-17RA are involved in the process of pulmonary fibrosis in rodents [62] [63]. IFN? 
is considered an anti-fibrotic cytokine. In addition to being a transcription factor for Th1 
differentiation T-bet is also a transcription factor for induction of IFN??in particular cells. 
Numerous studies have also investigated the role of T-bet in fibrosis. T-bet KO mice 
treated with bleomycin showed an increase in lung collagen content compared to WT 
mice [64]. Furthermore, in the absence of T-bet mice had increased hydroxyproline in the 
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skin following bleomycin treatment compared to WT counterparts [65]. 
HYPERSENSITIVITY PNEUMONITIS  
History  
In 1713, B. Ramazzini, an Italian medical professor, observed the health hazards 
in grain workers and stated “Almost all who make a living by sifting or measuring grain 
are short of breath and cachectic and rarely reach old age…” [3, 66]. With this 
description he gave the first account for what is now known as Hypersensitivity 
Pneumonitis (HP). In the 20th century, several published reports described outbreaks of 
respiratory diseases that were later defined as HP. In 1932, the initial clinical description 
of HP was developed following an outbreak of respiratory illness in a Michigan 
Company. The workers were stripping bark from maple logs and developed symptoms 
such as dyspnea, coughing, weight loss, and sputum. Similar symptoms appeared in 
labors working with maple logs at a nearby sawmill. At both locales, investigators found 
black dust lying beneath the bark from which they isolated a fungus called Cryptostroma 
corticale [67]. The authors hypothesized that the symptoms resulted from an allergic 
reaction to the spores of this microorganism. Another outbreak of respiratory disease was 
reported among agricultural workers who also developed weight loss and dyspnea in 
Northern England [68]. Once the workers ended their contact with hay, their symptoms 
disappeared within several weeks. Twelve years later, similar conditions were recognized 
and reported by W.N Pickles, a Yorkshire clinician.  He referred to the condition as 
farmer’s lung [66]. 
 
 
Different Types and Etiological Agents of HP 
 
Hypersensitivity pneumonitis (HP) is an interstitial lung disease caused by 
repeated inhalation of environmental antigens resulting in alveolitis, granuloma formation 
and sometimes fibrosis [3, 69-71]. There are a wide range of environmental agents that 
cause HP and they include animal proteins, fungi, and bacteria (Table 1-1). Each type of 
HP is named after the antigen, occupation, or hobby performed by the exposed individual 
[72]. For example, Farmer’s Lung Disease (FLD) is a classic example of HP caused by 
repeated exposure to thermophilic bacteria called Saccharopolyspora rectivirgula (SR)
[73]. SR (rectus=straight and virgula=twig) is an aerobic thermophilic gram positive 
spore-forming bacterium that belongs to the actinomycetes family. It has a type IV cell 
wall which contains meso diaminopimelic acid (meso-DAP), galactose, and arabinose. 
The bacteria grow in moldy hay as well as soil, compost, and manure [74]. When the hay 
is disturbed, the spores become airborne and inhaled by farmers. In eastern France, other 
organisms such as fungal species A. corymbifera, E. amstelodami, and W. sebi were 
isolated from cowshed air and fodder and identified as potential etiological agents for 
FLD in the absence of SR [75]. Different farming practices affect fungal and bacterial 
concentration in hay and subsequently the disease risk [76]. Other types of HP include 
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Table 1-1. Different forms of HP showing putative antigens and their source. 
Disease Antigen source Antigen 
Bird fancier’s lung Pigeon and parakeet Avian proteins  in feces and feathers 
Bagassosis Moldy cane sugar Thermophilic actinomycetes
Cheese worker’s lung Moldy cheese Penicillium casei 
Farmer’s lung Moldy hay Thermophilic actinomycetes 
Hot tub lung Contaminated warm water Mycobacterium avium 
Malt worker’s lung Moldy malt Aspergillus sp. 
Maple bark disease Maple logs Cryptostoroma corticle 
Machine worker’s lung Metal-cutting fluid Mycobacterium sp. and Gram-negative Bacilli 
Tobacco worker’s lung Moldy tobacco Aspergillus sp. 
Peat moss worker’s Moldy peat moss Penicillium sp. 
Suberosis Moldy cork Aspergillus sp. 
(Adapted with permission from Hirschmann, J.V., S.N. Pipavath, and J.D. Godwin, 
Hypersensitivity pneumonitis: a historical, clinical, and radiologic review. 
Radiographics, 2009. 29(7): p. 1921-38 and Dhar, S. and F. Daroowalla, Hypersenitivity
Pneumonitis. Clinical Pulmonary Medicine, 2011. 18(4): p. 169-174 [66, 77].) 
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Bird Fancier’s Lung, which results from exposure to avian proteins found in feathers, 
serum, or bird droppings [78]. Fungi are another source of HP antigens. For example, 
members of the Aspergillus species induce disease among corn and malt workers [79, 
80]. Also cheese, cork, and peat moss workers develop HP due to repeated exposure to 
Penicillium species [81-83]. The enzyme phytase that is added to cattle feed and, also 
molds from dry sausage have been described as a potential etiological agent for HP [84, 
85]. Despite the wide range of etiological agents, all HP types are characterized by 
alveolitis, and granuloma formation; some patients develop fibrosis, which is associated 
with significant morbidity and mortality [86]. 
 
 
Classification, Clinical Diagnosis, and Epidemiology 
 
HP Classification  
 
HP can be classified into acute, subacute and chronic forms [87]. Acute HP is the 
most common clinical presentation and is characterized by flu-like symptoms including 
chills, malaise, fever and myalgias. Other pulmonary symptoms, including a non-
productive cough, chest tightness, or dyspnea may accompany the acute form. The 
symptoms begin 2-9 hours after exposure and peak 6-24 hours after exposure then 
resolve without any treatment 1-3 days post exposure cessation [88]. The subacute form 
of HP is mainly characterized by a progressive cough, dyspnea, fatigue, weight loss, and 
granuloma formation. The symptoms develop with continuous exposure and occur within 
weeks to a few months of exposure [70, 89, 90]. The hallmark of chronic HP is 
progressive, irreversible pulmonary fibrosis that takes months to years to develop, with a 
mortality rate 1-10% [3]. There are conundrums surrounding this classification since 
there is a lot of overlap between HP stages and no accepted criteria to distinguish 
between the three stages. Recently, the classification of HP was revisited in a study [91]. 
The authors took advantage of a multicenter cohort HP study done between February 
1998 and September 2001 from seven clinical sites in different countries and performed 
cluster analysis to compare them to the current classification, i.e., acute, subacute, and 
chronic [92]. The results from the cluster analysis did not confirm the current 
classification, thus suggesting that HP patients are divided into two clusters. The first 
cluster of patients develop chest tightness after antigen exposure, body aches, and chills, 
with normal chest radiographs, while the second cluster is characterized by restrictive 
pulmonary function tests, resting hypoxemia, and inspiratory crackles. One third of this 
cluster develop fibrotic changes, as seen on High Resolution Computed Tomography 
(HRCT) [91]. In conclusion, the current classification was not verified by this study in 
which HP patients were classified into two categories rather than three; however, the 
authors mentioned that their classification requires further validation. 
 
HP Clinical Diagnosis 
 
There is no solid standard diagnostic test to rule out HP from other interstitial 
lung diseases [77]; however, a study proposed six diagnostic criteria for HP and when all 
six factors are present the probability of HP is 98%. The six criteria are as follows: 
12 
(1) Exposure to a known inciting agent, (2) loss of weight, (3) detection of precipitating 
antibodies from patient sera, (4) on physical examination, inspiratory crackles are 
present, (5) symptoms occur four to eight hours after exposure , and (6) the patient 
experiences recurrent episodes of symptoms [92]. Chest X-ray is usually the first step in 
the diagnosis of a patient with pulmonary disease. It mainly rules out other pulmonary 
diseases rather than HP. Up to 20% of patients with acute HP have normal X-rays 
[93].Usually the X-ray findings are not specific for HP showing the non-specificity of 
this approach. Another diagnostic approach is the detection of serum-precipitating 
antibodies. Several studies indicated that the presence of serum-precipitating antibodies 
doesn’t really reflect the occurrence of HP. For instance, it has been reported that up to 
50% of pigeon breeders and 30% of farmers develop serum-precipitating antibodies with 
no evidence of disease symptoms [94, 95]. Furthermore, 78% of subjects exposed to 
known antigens that cause HP had serum-precipitating antibodies while 38% of the 
control group subjects were diagnosed with serum-precipitating antibodies [92].There are 
several factors that contribute to the failure to detect serum-precipitating antibodies in a 
given patient, they include  usage of poorly purified antigens, lack of specificity, and 
diluted serum patient samples [96]. The antibody concentration in the serum is low in HP 
patients with smoking history [97-99]. In summary, serum-precipitating antibodies are 
good markers against specific antigens; however, their absence does not negate diagnosis 
with HP. Lung function tests are nonspecific for HP since the lung function changes are 
similar to other interstitial lung diseases [90]. In general all forms of HP display 
restrictive pattern of lung function, including reduced lung volumes and impairment in O2 
transfer from airspace to blood (Diffusing Capacity of Lung for Carbon monoxide, DLco), 
reduced compliance (the ability of the lungs to stretch back to their original size after 
removal of a compressing force), and hypoxemia induced by exercise [100].Analysis of 
the cellular composition of bronchoalveolar lavage (BAL) from patients is another tool to 
diagnose HP. During BAL a saline solution is injected into the lungs and then retrieved 
back to be examined by flow cytometry.  In normal healthy subjects, 90% of the retrieved 
cells are alveolar macrophages and the rest are lymphocytes, neutrophils and eosinophils 
[101]. During an acute HP episode neutrophils are the main cell population in the BAL 
within 48 hours of an  exposure [102] which become lymphocytic later on.  
 
The most effective way to manage HP is identifying the causative agent and 
avoiding exposure to it; however, it is difficult to identify the inciting agent and adding to 
that exposure cessation might put the patient’s daily work at risk. Complete cessation of 
exposure may help acute HP patients to experience a reversal of symptoms, but once the 
disease reaches the fibrotic stage it becomes irreversible.  This results in significant 
decline in lung function and can lead to death even if patients avoid exposure to the 
inciting agent. Although corticosteroids are another option to improve lung function; it 
does not replace the necessity of antigen identification and contact withdrawal [3, 77]. 
 
HP Epidemiology 
 
The incidence and prevalence of HP are variable and hard to determine for several 
reasons. The methods used to diagnose HP are limited, making HP often misdiagnosed as 
viral pneumonitis or idiopathic interstitial disease [90]. Also, most HP studies were 
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cross-sectional, while large scale surveys were few and mainly dependent on 
questionnaire and detection of serum-precipitating antibodies [77, 103]. As mentioned 
above, the presence of antibodies against specific antigen doesn’t rule out HP. The issue 
gets more complicated by geographical, climatic conditions and farming practices. 
Population studies have reported varying rates of HP incidence. In New Mexico, the 
incidence of HP between 1988-1990 was 0.6 per 100,000 cases, whereas the incidence of 
HP in Wisconsin dairy farmers was 42 per 100,000 [104, 105]. In the Czech Republic, 
the most common types of HP were Farmer’s lung, Malt worker’s lung and Chemical 
worker’s lung; however the  incidence between 1992 and 2005 was only 0-0.2 per 
100,000 workers[106]. In the UK, the most common types of HP were found in the 
agriculture, fishing, and forestry industries and the incidence 1992 and 2001 was 1.6%. 
[107]. Aside from the environmental factors and farming practices, genetic factors add 
another layer of complexity in the epidemiology of HP. For example, certain alleles of 
Major Histocompatibility Complex, TNF??promoter, and LMP2 and 7 (encode subunits 
in the proteosome complex for degradation of cytosolic proteins and generation of 
antigenic peptides) are associated with Pigeon breeder’s disease [108, 109]. In 
conclusion, combination of several factors is responsible for the variability in HP 
incidence and prevalence. 
 
 
Immunopathogenesis 
 
Immunopathogenesis of HP in Patients 
 
Despite the fact that a wide range of environmental agents may cause HP, the 
disease is characterized by alveolitis, granuloma formation and fibrosis. In HP patients, 
one of the hallmarks of the acute stage is neutrophilic alveolitis [102]. During acute HP, 
the patients were diagnosed with a significant increase in the BAL cell numbers as well 
as the percentage of neutrophils compared to control subjects [102]. Although CXCL2 
(IL-8), a neutrophil chemokine, was detected in the BALF of HP patients [110, 111], the 
source was not identified. Later on alveolar macrophages were discovered as the potential 
source of IL-8 in HP patients [112]. The recruitment of neutrophils into the air space of 
the lungs causes tissue damage through production of proteases and oxygen free radicals. 
In patients with lung fibrosis, there was an increase in the number of lung neutrophils as 
well as increase of matrix metalloproteinases (MMPs), MMP-8 and 9 compared to 
control subjects [113]. The correlation between fibrosis and production of MMPs by 
neutrophils suggested the role of neutrophils in tissue remodeling and eventually lung 
fibrosis [113]. In conclusion, the previous studies suggested that AMs initiate 
inflammatory environment in the air space by recruitment of neutrophils through IL-8 
and they play a pathogenic role during fibrosis stage in HP. 
 
CXCL2 is not the only chemokine produced by AMs. AMs isolated from HP 
patients spontaneously produce an array of cytokines and chemokines, which eventually 
contribute to macrophage and T cell recruitment and granuloma formation. For instance, 
in acute and chronic HP patients, AMs produce increased amounts of IL-12, IL-18, and 
TNF? without ex vivo stimulation compared to control subjects [114]. IFN? stimulates 
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macrophages to produce TNF? and IL-1? which further stimulates  macrophages to 
produce additional chemokines recruiting monocytes to the lungs for granuloma 
formation [115]. Furthermore, IFN? inducible chemokine CXCL10 is produced from 
AMs isolated from HP patients. Consequently, CXCL10 recruits T cells bearing the 
CXCR3 receptor especially CD8+ T cells into the lungs [116]. Additionally, 
CCL3/MIP-1???chemokine that contributes to recruitment of CD8+ T cells, was detected 
in the BALF from HP patients [111]. Several studies demonstrated that CD8+ T cells 
were the predominant T cells in the BAL of HP patients with acute and subacute stages, 
decreasing CD4+/CD8+ ratio; however, in the fibrosis stage CD4+ T cells were elevated 
increasing the CD4+/CD8+ ratio. These ratios could change based on the type of the 
antigen [117-120].  Although AMs are considered as poor antigen presenting cells, AMs 
isolated from HP patients are characterized by upregulation in HLA DR (MHCII) which 
binds to the T cell receptor (TCR), co-stimulatory molecules (CD80 and CD86) which 
bind to CD28 on the T cells, and Intracellular adhesion molecule-1 (ICAM-1) which 
binds to Lymphocyte Function Associated antigen-1 (LFA-1) on T cells increasing 
adhesion for T cell binding [121-123]. All these characteristics suggest they may be 
important for T cell activation. In conclusion, AMs appear to contribute to production of 
a wide range of cytokines and chemokines that create a proinflammatory environment 
leading to recruitment of different immune cells and eventually granuloma formation. 
 
Immunopathogenesis in an Experimental Animal Model 
 
Although the previous HP studies can give us an appreciation for how disease 
complexity, the studies are very limited regarding the number of samples and the 
techniques used. Therefore, several animal models have been used to unravel the intricate 
mechanisms behind the disease. The SR mouse model of HP mimics Farmer’s lung 
disease, and in this model C57BL/6J mice are repeatedly intranasally exposed to SR. 
Following one exposure there is a neutrophilic alveolitis that peaks at 24-48 hours 
followed by lymphocytosis at 48-72 hours. Bronchoalveolar lavage fluid (BALF) is 
characterized by an increase in proinflammatory cytokines and chemokines such as IL-6, 
TNF?, IL-1?, CCL2 and CCL3 [124]. With continued exposures for 3 days per week for 
three weeks the alveolitis becomes increasingly lymphocytic and there is the formation of 
peribronchiolar granulomas [103]. The development of fibrosis with chronic exposures in 
this model was an advantage for several studies to use and understand the role of 
different cells and mediators in fibrosis during HP [62, 125, 126]. 
 
The wide range of proinflammatory cytokines and chemokines found in the 
BALF could be produced by different types of cells in the lung following SR inhalation. 
Alveolar macrophages might be potential candidates for production of these mediators. In
vitro stimulation of macrophages cell line (J744A.1) and murine alveolar macrophages 
(AMs) with SR resulted in secretion of different cytokines and chemokines  such as 
CCL2, CCL3, IL-6, IL-12p40, TNF?, and IL-1?????????The combination of these 
mediators create a proinflammatory environment in the airspace. One of the 
consequences of a proinflammatory environment in the airspace is recruitment of 
immune cells:  neutrophils, monocytes, and T cells. Early neutrophilic influx into the 
airways is one of the hallmarks of acute HP [102]. CXCL2 (mouse homologue for IL-8) 
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was detected in the BALF of C57BL/6 mice following SR exposure; however, it was 
significantly lower in the BALF of MyD88 KO mice (Adaptor protein downstream 
TLRs) [127]. In the same line of evidence, SR stimulation of WT adherent spleen cells in
vitro induces CXCL2 production while MyD88 KO produces significantly less amount of 
CXCL2 protein [127]. In summary, SR induces production of proinflammatory mediators 
from lung cells e.g. alveolar macrophages resulting in a proinflammatory environment 
and recruitment of immune cells into the lungs and airspace. 
 
The continuous exposure to SR leads to recruitment of T cells and eventually 
granuloma formation which is IFN? dependent during HP [128]. However, the cellular 
source of IFN??was not identified at that period of time. Nance et al. identified 
neutrophils as an important source of IFN? required for granuloma formation [129]. IFN? 
induced recruitment of CXCR3+/ CD4+ T cells through induction of IFN? inducible 
chemokines I-TAC, MIG, and IP-10 during HP [130]. Furthermore, IFN???? mice 
exposed to SR did not develop granulomas while WT counterpart did, demonstrating the 
importance of IFN? in granuloma formation during HP [128]. Since IL-10 
(anti-inflammatory cytokine) antagonizes IFN? biological actions, the role of IL-10 was 
also examined during HP. Following three weeks of SR exposure, IL-10 KO mice 
developed more alveolitis and lung inflammation compared to WT exposed mice. Also, 
IL-10 KO mice were characterized by up regulation in the gene expression of TNF?, 
IL-1, and IFN? in the lungs compared to WT exposed mice. The replacement of IL-10 in 
IL-10 KO exposed mice dampened the inflammation compared to IL-10 KO mice 
without IL-10 replacement [131]. In summary, these data demonstrated that IFN? and 
IL-10 play a crucial role in the development of HP. 
 
As described above various cytokines and chemokines were produced generating 
a proinflammatory environment. TNF? is one of the proinflammatory cytokines that 
plays a crucial role in various biological activities during inflammation, e.g. AMs’ and 
neutrophils’ activation and stimulation of the endothelium. The role of TNF? during HP 
was examined [126, 132-134]. Following three weeks of SR exposure, mice treated with 
anti-TNF? were characterized by less inflammation in the airways and lung, down 
regulation of IL-1 in BALF, and decreased collagen deposition in the lungs compared to 
mice treated with control rabbit serum [126]. The decrease in lung collagen following 
anti-TNF? suggested inhibition of TGF? (profibrotic cytokine that induce collagen 
production) during HP. Consequently, levels of TGF? and collagen content were tested in 
the lungs of C57BL/6 mice during HP. There was a significant increase in the levels of 
lung TGF? following one week of SR exposure and increase in collagen content 
following two weeks of SR exposure compared to saline exposed mice. Furthermore, in
vitro stimulation of alveolar macrophages from SR exposed mice produced significant 
amounts of TGF? compared to AMs from saline exposed mice [125]. In conclusion, both 
TNF? and TGF? are required for development of HP. 
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HP as a T Cell-Mediated Disease 
More than 40 years ago, HP was considered as an antibody-mediated disease 
(Type III hypersensitivity reaction) in which the inhaled environmental antigen binds to 
an antibody, forming antigen-antibody immune complexes. The deposition of these 
immune complexes in the lung initiate the disease through activation of classical 
complement pathway and alveolar macrophages secreting inflammatory cytokines; 
hence, lung inflammation is initiated as discussed above. [99, 103]. However, several 
observations during HP were not supported by this idea. First, granuloma formation and 
lymphocytic bronchoalveolar lavage (BAL) support the notion that HP is indeed a 
cell-mediated disease (Type IV hypersensitivity pneumonitis). Second, lack of vasculitis 
(a hallmark of Type III hall marks) and failure to produce lesions similar to human 
patients upon passive transfer of hyper immune serum [86, 103]. Third, the disease may 
occur in individuals lacking antibodies [135]. Finally, asymptomatic individuals may also 
develop antibodies aganist HP antigens [95]. In conclusion, these observations support 
the importance of type IV hypersensitivity reaction over type III hypersensitivity reaction 
during HP. 
The discovery that humoral immunity (antibody mediated) does not play an 
important role in HP pathogenesis led the HP research field to change its view toward the 
disease and start to investigate the other arm of adaptive immunity, which is cellular 
immunity. Numerous studies have demonstrated the importance of T cells in the 
pathogenesis of the disease. C57BL/6 athymic nude mice (nu/nu), which lack T-cells, 
develop less lung inflammation compared to (+/nu) mice when exposed to 
Thermoactinomyces vulgaris, an HP causative agent [136]. To determine the role of 
T cells in this model, nu/nu mice were injected with splenic T cells obtained from 
sensitized +/nu-mice. The results demonstrated that  the recipients develop lung 
inflammation similar to +/nu-exposed mice, suggesting that  T cells play a pathogenic 
role [136]. However, it was unknown whether CD4+ or CD8+ T cells were responsible for 
the disease. Schuyler et al. demonstrated that adoptive transfer of CD4+ T cells but not 
CD8+ T cells from spleens or lung lymph nodes of SR sensitized mice into naïve mice 
resulted in lung inflammation [137]. Similarly, adoptive transfer of CD4+ T cells into 
TCR???double knockout mice (mice deficient in CD4+, CD8+ and ?? T-cells) resulted in 
lung inflammation and pulmonary fibrosis [62]. Finally, adoptive transfer of splenic cells 
treated with anti-CD4+ antibody from SR  sensitized mice failed to transfer the disease to 
naïve animals [138] confirming the pathogenic role of CD4+ T cells during HP. In 
conclusion, CD4+ T cells are pathogenic in HP. 
Role of Th1 Cells and IFN? during HP 
 
Initial studies suggested that HP was a Th1 cell-mediated disease rather than a 
Th2 cell-mediated disease.  Th1 biased C57BL/6 mice are susceptible to HP while the 
Th2 biased DBA/2 mice are resistant to HP [139, 140]. Also, GATA-3 knock-in 
transgenic mice develop a less severe form of HP than their WT counterparts [141]. 
Additionally, based on pulmonary histological changes, it was found that CD4+ T cells 
that adoptively transfer HP are Th1 but not Th2 cells [142]. Finally, knocking out 
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IFN???the Th1 signature cytokine protects SR exposed mice from granuloma formation 
while WT SR exposed mice develop granuloma [128]. In conclusion, these studies 
suggested that Th1 cells were important for the disease and that IFN? was necessary for 
granuloma formation. However, it was not clear whether IFN? produced by Th1 cells is 
required for disease severity during HP. Additional studies by our lab demonstrated that 
adoptive transfer of T cells from IFN? KO mice to RAG-1 KO mice (mice deficient in 
T and B cells), followed by exposure to SR, resulted in the same level of disease severity 
as adoptive transfer of WT T cells. These results demonstrated that T cell IFN? 
production was not necessary for the disease pathogenesis and that IFN? production by 
innate immune cells was sufficient. Therefore, the development of a Th1 response may 
not be necessary for the development of the disease [129]. These data clearly demonstrate 
that IFN? produced by Th1 is not required for granuloma formation and a non-T cell 
IFN? source is sufficient for granuloma formation. Using intracellular cytokine staining, 
the innate immune source of IFN??was identified as neutrophils. Depletion of neutrophils 
causes down-regulation of IFN? at both the mRNA and protein levels, confirming the 
importance of neutrophils as a significant source of IFN? during HP [129]. In conclusion, 
the previous studies suggested that HP was a Th1-mediated disease; however, IFN? 
produced by Th1 cells is not necessary for granuloma formation. 
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CHAPTER 2.   HP AND TH17 
While it was once thought that HP is a Th1 cell mediated disease, the results 
demonstrating that IFN? produced by Th1 cells was dispensable for granuloma formation 
suggested otherwise. Consequently, we examined the T cell response during HP in an 
attempt to determine whether a Th17 response rather than a Th1 response could be 
responsible for the disease.  The aim of these studies is to determine whether a Th17 
response developed in the mice during the granulomatous and chronic phases of HP.  
 
 
INTRODUCTION 
Th17 Cell as a Distinct CD4+ T Helper Cell   
 
The past few years have witnessed a revolution in the field of T helper cell 
biology with the discovery of an additional effector T helper cell subset, Th17 cells. 
These cells are characterized by their own distinct transcription factors, (ROR?t and 
ROR?? and signature cytokines (IL-17A, IL-17F, IL-21, and IL-22) [19-22]. Th17 cell 
differentiation is induced by the combination of IL-6 and TGF?? [15-18]. Both cytokines 
cooperate together for induction of ROR?t which is required for IL-17A and IL-17F 
mRNA expression [19]. To further demonstrate the importance of IL-6 and TGF? in 
Th17 differentiation,  studies have shown that absence of TGF? receptor resulted in a 
defect in generation of Th17 cells, while TGF? transgenic mice have a higher frequency 
of Th17 cells following induction of Experimental Autoimmune Encephalomyelitis 
(EAE, a mouse model for multiple sclerosis) [18, 143]. Similarly, IL-6 KO mice lack 
Th17 cells; however, the dominant cell response is mediated by T regulatory cells (Tregs) 
showing the inhibitory effect of IL-6 on TGF? driven Foxp3 expression. Nevertheless, 
depletion of Tregs in IL-6 KO mice restores Th17 cell differentiation, indicating the 
presence of another factor besides IL-6 for Th17 differentiation, IL-21 [144]. Since IL-21 
is produced by Th17 cells, IL-21 in an autocrine manner, together with TGF?? is able to 
induce Th17 cell differentiation independently of IL-6 [144-146]. All the previous 
characteristics made Th17 classified as a distinct subset of CD4+ helper T cells. 
IL-23 is a member of the IL-12 family of cytokines that consists of 2 chains, 
IL-23 p19 specific for IL-23 and the IL-12p40 that is common with IL-12 [147]. Since, 
IL-23R is not expressed by naïve T cells, IL-23 is not involved in Th17 differentiation; 
however, IL-23R is expressed on differentiated Th17 cells. In vitro data showed that 
IL-23 is required for IL-17 secretion from Th17 cells but not for their proliferation and 
commitment [148]. The role of IL-23 in several disease models was examined. For 
example, it was shown that IL-23p19KO mice were protected from induction of EAE 
[149]. Furthermore, Th17 cells cultured in vitro with IL-23 were able to transfer EAE 
[150, 151]. These Th17 cells acquired pathogenic characteristics, whereas Th17 
generated in presence of IL-6 and TGF? only were did not induce disease due to 
anti-inflammatory cytokine IL-10 production [152]. Recently, this idea was supported by 
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a study showing that naïve T cells cultured in the presence of IL-6, IL-1?, and IL-23 
possess a pathogenic characteristic and able to transfer EAE to the mice via adoptive 
transfer while culturing in the presence of IL-6 and TGF? only made them non-
pathogenic [153]. More than 2,000 genes were differentially expressed between both 
types of cells, showing that both have different expression profiles [153]. Although these 
studies demonstrated the importance of IL-23 for Th17 pathogenicity in an autoimmune 
disease model, the factor(s) downstream of IL-23 remained to be identified. Several 
studies demonstrated that Granulocyte/Macrophage Colony Stimulating Factor 
(GM-CSF) was produced by Th17 cells following IL-23 stimulation [150, 154, 155]. 
GM-CSF plays a pathogenic role in EAE. Neutralization of GM-CSF inhibits 
development of EAE and enhances the recovery [155]. Antigen presenting cells express 
the GM-CSF receptor whereas T cells do not and the main action of GM-CSF is to 
upregulate MHCII and proinflammatory cytokines, e.g., IL-6. In EAE, GM-CSF deficient 
mice have reduced MHCII expression on microglial cells [155] with less accumulation of 
macrophages into the CNS [156]. Also, GM-CSF was shown to stimulate IL-23 from 
dendritic cells, causing activation of Th17 cells and formation of IL-23-GM-CSF positive 
feedback loop [154]. To conclude, IL-23 plays a role in the pathogenicity of Th17 cells. 
 
 
Effector Function of Th17 Cytokines 
 
Although IL-17 is considered the signature cytokine of Th17, it is expressed by 
other immune cells [157-159]. IL-17 (also known as IL-17A) belongs to the IL-17 family 
of cytokines which includes IL-17B-IL-17F members. It plays a role in host defense and 
inflammation by induction of proinflammatory cytokines (IL-1, TNF?, and IL-6), 
chemokines (CXCL1, CXCL2, CCL2, and CCL7), matrix metalloproteinases (MMP1, 3, 
and 13) and antimicrobial peptides (defensins and S100 proteins). Furthermore, IL-17 is 
involved in granulopoiesis and neutrophil recruitment by induction of G-CSF and 
neutrophil chemokines such as CXCL2 [160]. Previous studies demonstrated the 
correlation between IL-17 and airway neutrophil recruitment [161-163]. Administration 
of exogenous IL-17 induced neutrophil recruitment as well as upregulation in neutrophil 
chemokine, CXCL2 [161-163]. Following LPS intranasal administration, there was an 
increase in IL-17 protein expression in the BALF accompanied by an influx of 
neutrophils into the airways [162]. Moreover, IL-17 neutralization results in a decrease in 
the number of airway neutrophils and CXCL2 protein expression in BALF [162] and 
IL-8 secretion from 16HBE, human bronchoepithelial cells [161]. Taken together, these 
studies emphasize the importance of IL-17 in regulation of neutrophil recruitment into 
airways. 
 
IL-22 is another cytokine secreted by Th17 cells, although it is also expressed by 
a wide range of innate and adaptive immune cells e.g. NK cells, NKT cells, ?? T cells, 
dendritic cells, and CD8 T cells. The IL-22 receptor is expressed on nonhematopioetic 
cells lining barrier surfaces such as  lung, intestine, and skin as well as liver and kidneys 
[164]. Several studies demonstrated the protective effect of IL-22 on airway and 
intestinal epithelium through induction of antimicrobial peptides and enhancement of 
epithelial barrier integrity [28, 30]. Also, IL-22 induces expression of chemokines and 
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cytokines CXCL1, CXCL5, CXCL9, IL-6, and G-CSF required for host defense against 
bacterial infection [28, 30]. Furthermore, IL-22 induces wound healing by increasing cell 
migration in intestinal epithelial and keratinocyte in vitro wound assay [165, 166]. IL-22 
also stimulates expression of  antiapoptotic molecules e.g. BcL-2, BcL-xL as well as 
protective mucin (muc1, muc3, muc10, and muc13) [164]. In a mouse model of 
hypersensitivity pneumonitis, blocking IL-22 increases collagen deposition in the lungs 
while injection of IL-22 prevents lung fibrosis. On the contrary, IL-22 promotes 
pathological effects as well. For example, IL-23 stimulates dermal inflammation in an 
IL-22 dependant fashion. In the same line of evidence, IL-22 KO mice were 
characterized by decreased inflammation and epidermal hyperplasia in psoriasis mouse 
model [167]. Furthermore, neutralization of IL-22 in psoriasis-like skin disease 
ameliorates the disease severity and decreases expression of antimicrobial peptides [168]. 
To conclude, the previous results demonstrated the pathological and protective role of 
IL-22 in different experimental animal models.  
 
 
Is HP a Th1/Th17-Mediated Disease? 
 
HP was once considered as a Th1 mediated disease for several reasons. Several 
studies demonstrated the importance of Th1 cells in HP, while other studies demonstrated 
the importance of the Th1 cytokine IFN?? IFN? knockout mice (GKO) when exposed to 
SR did not develop granulomas compared to the WT mice [128]. Previous results from 
our lab demonstrated that T cell IFN? production was not necessary for the disease and 
that IFN? production by innate immune cells was sufficient. Therefore, the development 
of a Th1 response may not be necessary for the development of the disease [129]. 
However, since T cells are necessary for granuloma formation, is there is another CD4+
T cell subset, such as Th17 or Th2 cells, required for disease severity?  The objective of 
this chapter is to determine the T cell response (beside Th1 response) that develops 
during the granulomatous and chronic phases of HP. 
MATERIALS AND METHODS 
 
 
Bacterial Preparation and Exposure Protocol 
 
Bacterial Preparation 
 
SR was obtained from the American Type Culture Collection (strain designation 
A1313; ATCC, Rockville, MD). It is a thermophilic gram-positive bacterium formerly 
known as Micropolyspora faeni belonging to the Pseudonocardiacecae family. The 
bacterium was grown in Trypticase Soy Broth (BD; Sparks, MD) at 55oC in a shaking 
incubator then harvested by centrifugation at 2000 rpm for 15 minutes and washed with 
sterile endotoxin free water three times followed by lyophilization. The lyophilized 
preparation was reconstituted at a concentration of 5mg/ml in endotoxin-free saline and 
determined to be endotoxin free using the Limulus ambeocyte lysate assay (Lonza; 
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Walkersville, MD). This preparation was used for intranasal exposures. 
SR Exposure Protocol 
Mice were anesthetized using isoflurane and SR (50-225?g/ml) was inoculated 
intranasally in a total volume of 40?l. To study the innate immune response following 
exposure to SR, mice were exposed once or twice and sacrificed 24 hours after the last 
exposure. Studies on granuloma formation and the adaptive immune response were 
performed after three weeks of exposure. Mice were intranasally exposed to SR on 3 
consecutive days per week for three weeks (Fig. 2-1) and sacrificed 18 hours after the last 
exposure (Day 18) or 4 days after the last exposure (Day 21). To examine the immune 
response during chronic HP mice were intranasally inoculated with SR for 3 days per 
week for 25 weeks. All experiments included unexposed mice or saline exposed as 
negative controls. 
 
 
Cell Culture Medium 
 
RPMI (Cellgro, Mediatech Inc., Manassas, VA) containing 5% heat-inactivated 
FCS (Hyclone; Rockford, IL), Glutamine (2mM), Penicillin/Streptomycin (100U/ml and 
100?g/ml) (GIBCO cell culture Invitrogen; Carlsbad, CA) and 2nM 2-Mercaptoethanol 
(Fisher scientific; Pittsburgh, PA) was used in spleen and lung cell isolation experiments. 
 
 
Bronchoalveolar Lavage (BAL) and Lung Cell Isolation 
 
Mice were euthanized by CO2 asphyxiation and bronchoalveolar lavage (BAL) 
was performed by intratracheal injection of 1 ml of PBS into the lung with immediate 
aspiration. The amount of fluid recovered was routinely 70%-80%. To determine the 
extent of alveolitis in individual mice the BAL cells were recovered by centrifugation and 
live cells were counted using Trypan blue dye exclusion (Cellgro; Mediatech Inc., 
Manassas, VA). The BAL fluid was frozen at -80oC until used in Enzyme Linked 
Immunosorbent Assay (ELISA) for cytokine and chemokine measurement. 
 
To prepare single lung cell suspensions, lungs were perfused with sterile PBS to 
remove circulatory cells and lung lobes were removed. The lung lobes were minced into 
small pieces and digested with Collagenease 20U/ml and Deoxyribonuclease I 40?g/ml 
(Sigma-Aldrich, St. Louis, MO) for 45 minutes at 37oC. The digested tissue was 
disrupted using a Stomacher® 80 tissue processor (Brinkman Instruments, Westbury, 
 
 
     Day        1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 
                SR exposure 
 
 
Figure 2-1. Three week SR exposure.  
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NY) and debris removed by passage through a 70?M strainer (BD falcon). The cell 
suspension was layered on a discontinuous gradient consisting of 40% and 80% percoll 
(Sigma-Aldrich, St. Louis, MO). The cells were collected at the 40% - 80% percoll 
interface following centrifugation at 2000 rpm for 20 minutes. The cells were washed 
with sterile PBS and live cells counted using Trypan Blue exclusion dye. 
 
 
RNA Extraction and Semi-Quantitative RT-PCR 
 
RNA Extraction 
 
Total RNA was extracted from one lung lobe of individual mice using Trizol® 
(Invitrogen, Carlsbad, CA). Contaminating genomic DNA was removed by treating the 
RNA samples with DNase (Turbo DNA free, Ambion, Austin, TX). RNA concentration 
was determined by measuring the absorbance of UV light at 260nm, and 280nm using 
Ultraspec 2000 spectrophotometer (Pharmacia Biotech, Piscataway, NJ). The 
concentration of RNA (μg/ml) was calculated by multiplying the absorbance (A260), the 
dilution factor and 40μg/ml. To determine the quality of the RNA 1-2?g were loaded on 
a 4% agarose gel and analyzed for the presence of 18S and 28S ribosomal RNA subunits 
as an indicator of intact RNA. 
 
Semi-Quantitative RT-PCR 
 
Two ?g of RNA from individual samples was reverse transcribed into cDNA 
using a Promega Reverse Transcription System kit following manufacturer’s instructions 
(Promega, Madison, WI). The cDNA synthesized from RNA was used as a template for 
end point PCR to be amplified using Taq Polymerase (Promega, Madison, WI). For 
semi-quantitave PCR, each PCR cycle was run with a denaturation step at 95oC for 30 
seconds, followed by an annealing step at a primer-specific temperature (Table 2-1) for 
30 seconds and an extension step at 72oC for 30 seconds. All the reactions were amplified 
for 35 cycles, except for ?-actin, which was amplified for 28 cycles. After amplification 
20?l of product were loaded on a 1.8% agarose gel to be separated by agarose gel 
electrophoresis. The separated bands were visualized using ethidum bromide staining and 
were detected using an Alpha Image 2200 Multi-image light cabinet and alphaEase FC 
software (Alpha Innotech Corporation, San Leandro, CA). 
 
 
Flow Cytometry 
 
Cell Surface Staining 
 
Phenotyping of BAL cells and lung cells was performed using flow cytometry. 
Cells (2x105cells/tube) were incubated for 15 minutes on ice with 0.1?g/ml Fc block 
(Anti-CD16/CD32 antibody) [BD Biosciences, San Diego, CA] to block Fc receptors. 
The cells were washed with 1ml FACS Buffer (PBS + 3%FCS) and centrifuged for 5 
minutes at 1500 rpm. The cell pellet was resuspended in approximately 200?l FACS  
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Table 2-1. List of PCR primers used for PCR. 
Primer 
name 
Forward 
primer 
Reverse 
primer 
Product 
length 
(bp) 
Anneal. 
temp. 
(oC) 
IL-4 TCG GCA TTT TGA ACG AGG TC 
GAA AAG CCC GAA 
AGA GTC TC 261 60 
IL-6 GAC AAA GCC AGA GTC CTT CAG AGA G 
CTA GGT TTG CCG 
AGT AGA TCT C 229 60 
IL-17 CTC CAG AAG GCC CTC AGA CTA C 
AGC TTT CCC TCC 
GCA TTG ACA CAG 142 60 
IFN? TCA AGT GGC ATA GAT GTG GAA GAA 
TGG CTC TGC AGG 
ATT TTC ATG 92 60 
CXCL2 TGG GTG GGA TGT AGC TAG TTC C 
GT TTG CCT TGA 
CCC TGA AGC C 285 65 
T-bet GCC AGG GAA CCG CTT ATA TG 
GAC GAT CAT CTG 
GGT CAC ATT GT 136 60.2 
Human 
ROR?t 
CCG CTG AGA GGG 
CTT CAC 
TGC AGG AGT AGG 
CCA CAT TAC 110 60 
?-Actin GTG GGC CGC TCT AGG CAC CA 
CGG TTG GCC TTA 
GGG TTC AGG 
GGGG 
245 60 
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buffer and incubated with fluorochrome-conjugated antibodies specific for surface  
markers (Table 2-2) for 30 min on ice in the dark. The cells were washed twice with 
FACS Buffer and resuspended in a final volume of 200?l FACS Buffer prior to analysis 
using a BD LSRII (BD, San Diego, CA) flow cytometer. Approximately, 30,000 to 
50,000 events/tube were collected and the data was analyzed using FACSDiva Software 
(version 5.02). 
 
Preparation of Bacterial Lysate for Intracellular Cytokine Staining 
 
SR lysate was prepared by using Y-PER reagent (PIERCE, Rockford, IL). One 
gm of lyophilized SR was incubated with 7.5ml of Y-PER reagent for 20 minutes at room 
temperature with gentle rocking followed by three cycles of freeze and thaw 5 minutes 
each. The bacterial suspension was centrifuged at 8500rpm for 5 minutes at 4°C and the 
supernatant collected. The SR lysate was diluted in 10-20 volumes of PBS to remove 
SDS and concentrated using Y-10 concentrators (Millipore; Billerica, MA). The protein 
concentration in the SR lysate was measured using Bio-Rad protein assay following 
manufacturer’s instructions (Bio-Rad Laboratories; Hercules, CA). 
 
Intracellular Cytokine Staining 
 
Intracellular cytokine staining was used to identify Th1 and Th17 cells. For Th1 
or Th17 cell determination, lung cells were isolated from mice exposed to SR for three 
weeks. In a 96 well plate, at least 2x105cells/well were plated and stimulated with media, 
SR lysate (20?g/ml), or anti-CD3 antibody (10?g/ml) for 7 hrs at 37°C. Golgi plug (BD 
Biosciences, San Diego, CA) was added for the final 4 hours of the culture to inhibit 
protein secretion. Cells were harvested and cell surface staining performed using 
antibodies to CD4, ?TCR, and CD11b. Cells were fixed using ????l BD Cytofix (BD 
Biosciences, San Diego, CA) for 15 minutes on ice and washed twice with 
permeabilization washing buffer (0.5% BSA + 0.5% Saponin in PBS). The cells were 
incubated with anti-IFN?, anti-IL-17, or anti-IL-6 antibody for 30-45 minutes on ice, 
washed twice and analyzed on the BD LSRII.  
 
 
Histology 
 
The perfused left lung lobe was harvested and fixed overnight in neutral buffered 
formalin at 4oC. The lung tissue was embedded in paraffin and sectioned into 8 ?m 
sections and stained with Hematoxylin and Eosin (H&E) by the Department of 
Pathology, UTHSC. 
 
 
Statistical Analysis 
 
Values were expressed as means ±SD. For comparison of means between two 
populations of unpaired data, unpaired student’s t-test was used. For comparison between 
more than two groups, One-way ANOVA followed by Tukey’s post ANOVA test was  
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Table 2-2. Characterization of innate and adaptive immune cell surface and 
intracellular markers. 
Cell population Cell markers 
Neutrophils CD45
+, CD11b+, Gr-1hi or 
Ly6G+ 
Alveolar macrophages CD45
+, CD11c+, CD11b-, 
CD205+, F4/80+ 
Interstitial macrophages CD45+, CD11c-, F4/80+ 
NK cells CD45+, NK1.1+ 
T cells CD45+, TCR?+ 
CD4 T cells CD45+, TCR?+ , CD4+ 
CD8 T cells CD45+, TCR?+ , CD8+ 
TH1 CD45+, TCR?+ , CD4+, IFN?+ 
TH17 CD45+, TCR?+ , CD4+, IL-17+ 
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used. GraphPad Prism 5 was used to perform all tests. Differences were considered 
significant at P <0.05. 
RESULTS 
 
 
Characterization of BAL Composition during Acute HP 
 
Measurement of alveolitis and characterization of BAL cellular composition are 
parameters to assess disease severity during HP. We analyzed the cell population in the 
airways by exposing C57BL/6J mice to SR. Following two daily exposures of SR (50 ?g 
each), mice were sacrificed and BAL was performed. Cells were collected and counted 
for phenotypic characterization by flow cytometry. In exposed mice, we found a 
significant increase in alveolitis compared to unexposed control mice. Furthermore, there 
was an influx of neutrophils which represent approximately 80% of the total cells in the 
airways but there was no difference in the percentage of NK cells between SR exposed 
and unexposed mice (Table 2-3). In conclusion, acute HP is characterized by neutrophilic 
alveolitis. 
 
 
Expression of IL-17 and CXCL2 during Acute Phase of HP 
 
In the previous section, we demonstrated that acute HP was associated with 
neutrophilic alveolitis. Since IL-17 has been demonstrated to induce neutrophil 
 
 
Table 2-3.  C57BL/6J mice develop alveolitis and airway neutrophilia following 
acute exposure to SR compared to unexposed mice. 
 
Mice Alveolitisa (±SD) PMNb % (±SD) NK cells
b % 
(±SD) 
Unexposed 
C57BL/6J 0.19x10
6 (±0.14) 1.57 (±0.9) 0.5 (±0.38) 
Exposed 
C57BL/6J 2.15x10
6 (±0.6)** 77.45 (±7.1)*** 1.55 (±0.46) 
C57BL/6J mice (n=3-4/group) were exposed to SR twice (50?g each). 
a BAL was performed and recovered cells were counted using Trypan Blue dye exclusion 
to exclude dead cells 
b Cells isolated from the BAL fluid were incubated with antibodies to various cell surface 
markers and analyzed by flow cytometry to determine cellular composition of the BALF. 
PMNs were identified as CD11b+/Gr-1hi. NK cells were identified as NK1.1+ cells. 
Results were expressed as means ±SD. Using unpaired student’s t-test, the mean of the 
unexposed group was compared to the exposed group. (**P<0.005 and ***P<0.0001 
significant difference from the unexposed group.) 
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chemokines e.g. CXCL1, CXCL2, and CXCL5 [161-163], we investigated whether there 
was an upregulation in IL-17 mRNA expression accompanied by upregulation in 
neutrophil chemokine (CXCL2) and neutrophilic alveolitis during acute HP. To fulfill 
this aim, mice were exposed twice daily to 50μg SR and lung IL-17 and CXCL2 mRNA 
expression were analyzed by semi-quantitative RT-PCR.  RNA was isolated from lung 
homogenates of individual mice, reverse transcribed into cDNA and PCR was performed 
using primers specific for CXCL2 and IL-17. The results demonstrated that both IL-17 
and CXCL2 mRNA expression increased following SR exposure as compared to 
unexposed mice (Fig. 2-2). These data demonstrated a correlation between neutrophil 
influx and IL-17 expression. 
Acute HP Is Associated with Th17 Differentiation and Effector Cytokines 
 Several disease models associated with Th17 response were characterized by a 
neutrophil-rich environment [169, 170]. During acute HP, we determined that HP is 
associated with IL-17 upregulation and neutrophilic alveolitis suggesting that HP is a 
Th17-mediated disease. Therefore, we examined the cytokines associated with Th17 
response as well as its differentiation to determine whether they were present during the 
acute phase of HP. To fulfill this aim, C57BL/6J mice were exposed one time to 100?g 
SR and cytokine expression was analyzed by semi-quantitative RT-PCR.  RNA was 
isolated from lung homogenates from individual mice 1, 3, 6, and 24 hours after SR 
exposure then reverse transcribed into cDNA to perform PCR using primers specific for 
IL-6, IL-21, IL-22 and IL-23. The housekeeping gene ?-actin was used as an internal 
control. We found an upregulation in the proinflammatory cytokine IL-6 that is required 
for Th17 differentiation along with TGF? (Fig. 2-3). IL-6 was upregulated at 1 hour post 
SR exposure and then it was downregulated at 24 hours. We found a slight upregulation 
in IL-22 which started following three hours of SR exposure. There was a weak 
expression in IL-21. Our data demonstrated weak expression of IL-23p19 which started 
at three hours and decreased by 24 hours. In conclusion, these results demonstrated the 
presence of cytokines associated with Th17 response and differentiation during acute HP. 
 
 
Characterization of BAL Composition during Granulomatous HP 
  
Continuous exposure to SR results in a disease shift towards the granulomatous 
stage. The hallmarks of the granulomatous phase of HP are granuloma formation in the 
peribronchiolar areas of the lungs and lymphocytic alveolitis. In contrast to acute HP, in 
granulomatous HP we found that neutrophils represented approximately 15% (±1.32) of 
the total BAL composition; however, T cells represent 26% (±6.2) of the total cells while 
CD4+ T cells represented 18% (±4.9) of the total cells (Table 2-4). There was no 
difference in the percentage of NK cells. In conclusion, the results demonstrated a 
lymphocytic rather than neutrophilic alveolitis during granulomatous HP. 
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Figure 2-2. Expression of IL-17 and CXCL2 (MIP-2) during acute HP. 
C57BL/6J mice (4/group) were exposed two times to SR (50?g). Total RNA was 
extracted from one lung lobe of individual unexposed and exposed mice then reverse 
transcribed into cDNA to use in RT- PCR using primers specific for IL-17 and CXCL2. 
The housekeeping gene ?-actin was used as an internal control. 
Figure 2-3. mRNA expression of Th17 cytokines during acute HP. 
  
C57BL/6J mice (n=3) were exposed to100?g SR then sacrificed after 1, 3, 6, or 24 hrs. 
Total RNA was extracted from one lung lobe of unexposed and exposed SR individual 
mice then reverse transcribed into cDNA to use in RT- PCR using primers specific for 
IL-6, IL-21, IL-22 and IL-23p19. The housekeeping gene??-actin was used as an internal 
control. 
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Table 2-4. C57BL/6J mice develop lymphocytic alveolitis during granulomatous 
HP. 
Mice Alveolitis
a 
(±SD) 
PMNb 
% (±SD) 
NK cellsb 
% (±SD) 
T cellsb 
% (±SD) 
CD4+ 
T cellsb 
% (±SD) 
Unexposed 
C57BL/6J 
0.3x106 
(±0.13) 
1.66 
(±0.71) 
15 
(±0.38) 
4.8 
(±0.92) 
4.03 
(±0.7) 
SR
Exposed 
C57BL/6J
5x106 
(±1.6)** 
14.9 
(±1.32)*** 
13.9 
(±4.2) 
25.96 
(±6.2)** 
18.4 
(±4.9)** 
C57BL/6J mice (n=3/group) were exposed to SR (200?g each) three times a week for 
three weeks then sacrificed 4 days following last exposure. 
a BAL was performed and recovered cells were counted using Trypan Blue dye 
exclusion. 
b Cells isolated from the BAL fluid were incubated with antibodies to various cell surface 
markers and analyzed by flow cytometry to determine cellular composition of the BALF. 
PMNs were identified as CD11b+/Gr-1hi. NK cells were identified as NK1.1+ cells. T 
cells were identified as TCR????CD4+ T cells were identified as TCR???CD4+. Results 
were expressed as means ±SD. Using unpaired student’s t-test, the mean of the 
unexposed group was compared to the exposed group. (??P<??????and????P???????, 
significant difference from the unexposed group.)  
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Granuloma Formation during Granulamatous HP 
One of the hallmarks of HP is granuloma formation that is typically found in the 
peribronchiolar regions. To demonstrate that mice exposed to SR for three weeks develop 
this form of the disease, H&E staining was performed on lung lobes isolated from 
exposed and unexposed mice (Fig. 2-4). The results demonstrated peribronchiolar 
granuloma in the lung interstitum. At this time point, if exposures were stopped, the 
granulomas resolved and the lung returned to normal (Fitzpatrick unpublished data).  
 
 
Granulomatous HP Is Associated with Activated CD4+ T Cells 
 
Granuloma formation in HP is T cell dependent; therefore, we examined the 
phenotype and activation state of the cells infiltrating the lung after 3 weeks of SR 
exposure. Following 3 weeks of SR exposure, unexposed or SR exposed mice were 
sacrificed at 4 days following last exposure. We isolated lung cells from mice exposed to 
SR for 3 weeks to determine the percentage and activation status of the T cells as well as 
innate cells. Single lung cell suspensions were prepared and  incubated with 
fluorochrome conjugated antibodies to CD45, NK1.1, Gr-1, CD4, TCR? chain, the early 
activation marker CD69 and CD25 (IL-2?R, IL-2 high affinity receptor subunit). 
 
 
 
 
Figure 2-4. Peribronchiolar granuloma formation following 3 weeks of SR 
exposure. 
 
Following 3 weeks of SR exposure, C57BL/6J mice were sacrificed and one lung lobe 
was used for H&E staining. Staining lung sections from unexposed or SR exposed mice 
showed granuloma formation in the exposed mice (Original magnification 63X). Panel A 
represents lung section from unexposed mouse. Panel B represents lung section from SR 
exposed mouse. 
  
A B 
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The results demonstrated an increase in the percentage of T cells (16% ±3.6) in 
the lungs of exposed mice compared to unexposed mice (13% ±1.8) (Fig. 2-5). Also, 
there was an increase in CD4+ T cells (13% ±3.1) in the lungs of SR exposed mice 
compared to unexposed mice (7.5% ±1.6). Furthermore, the CD4+ T cells from exposed 
mice were activated as measured by expression of the activation marker CD69. SR 
exposed mice showed a signficant increase in the percentage of CD4+/CD69+ T cells 
compared to unexposed mice (6% ±2.2 Vs. 0.7% ±0.2). However, we did not detect a 
signficant difference in CD25 (IL-2R) expression between unexposed and exposed 
groups. Interestingly, there was a signficant decrease in the percentage of NK cells in 
exposed mice compared to unexposed mice although this may be a dilutional effect. 
Finally, there was no difference in the percentage of PMNs between unexposed and SR 
exposed mice. In conclusion, granulomatous HP is associated with activated CD4+ T cells 
in the lungs. 
Granulomatous HP Is Associated with Th17 Immune Response 
In the previous section we found an influx of activated CD4+ T cells into the 
lungs; however, we do not know the type of these cells, i.e., Th1, Th2, or Th17. To 
determine the type of these cells, we used semi-quantitative RT-PCR to measure 
expression of T cell differentiation factors and cytokines. Following three weeks of SR 
exposure, total RNA was isolated from individual lung lobes of exposed mice as well as 
unexposed mice. Semi-quantitative RT-PCR was performed using primers for the Th1 
cytokine IFN? and the Th1transcription factor T-bet, the Th2 cytokine IL-4, Th17 
cytokine IL-17 and Th17 transcription factor ROR?t. 
The results demonstrated a faint band for IL-4 in 2 / 3 exposed mice suggesting 
there was not much of a Th2 response developing at this time point.  IFN??mRNA was 
increased in the exposed mice compared to the unexposed mice, demonstrating that this 
cytokine is associated with granulomatous inflammation; however, the Th1 transcription 
factor T-bet did not increase at the time points we examined. Since, both IL-17 and the 
Th17 transcription factor ROR?t expression were upregulated, these data suggest the 
development of Th17 response during this stage of the disease (Fig. 2-6). 
 
The upregulation of IL-17 and ROR?t mRNA in the lung homogenates suggested 
that Th17 cells had migrated into the lungs following SR exposure. In order to measure 
the frequency of Th1 and Th17 cells in the lungs, we performed intracellular cytokine 
staining. Mice were exposed to SR for 3 weeks and then lung cells were isolated and 
stimulated ex vivo with media or SR lysate for 6 hrs. Flow cytometry was performed 
using antibodies against CD45, CD4, IL-17 and IFN?? We found an average of 16% ±1.7 
Th17 cells and 1.1% ±0.3 Th1 cells in the lungs of SR exposed mice following ex vivo 
SR stimulation and an average of 0.36% ±0.15 Th17 cells vs. 0.33% ±0.3  Th1 cells in 
presence of media only. We also detected approximately 0.52% ±0.2 IFN?+/IL-17+ CD4+ 
T cells following SR stimulation (Fig. 2-7). In conclusion, granulomatous HP is 
associated predominately with a Th17 response and a low frequency of Th1 cells 
confirming the semi-quantitative RT-PCR results. 
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Figure 2-5. Cell surface staining showing the average percentage of different cell 
populations in the lung interstium of unexposed and SR exposed mice following 3 
weeks of SR exposure. 
 
Total immune lung cells were isolated from unexposed (n=3) and exposed mice (200?g 
SR for 3 weeks of exposure) then sacrificed 4 days later. Cells were stained for CD45, 
NK1.1, CD11b, TCR?, CD4, CD69, and CD25. Data was acquired on LSRII using FACS 
Diva Software. Approximately, 25,000 - 30,000 events were collected. Cells were gated 
as follows for NK cells CD45+/NK1.1+, PMNs CD45+/CD11b+/Gr-1hi , T cells 
CD45?/TCR?+, CD4+ T cells CD45+/TCR?+/CD4+, activated T cells as 
CD45+/TCR?+/CD4+/CD69+ or CD25+. Results were expressed as means ±SD. Using 
unpaired student’s t-test, mean of the unexposed group was compared to the exposed 
group. (*P<0.02 and **P<0.002, significant difference from unexposed group.)  
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Figure 2-6. mRNA expression of different cytokines and T cell transcription 
factors from unexposed and SR exposed mice during granulomatous HP. 
 
C57BL/6J mice (n=3) were exposed to 200?g SR for three weeks then sacrificed 4 days 
following last exposure. Unexposed mice were used also as controls. Total RNA was 
extracted from one lung lobe of individual mice and reverse transcribed into cDNA to use 
in semi-quantitative RT- PCR using primers specific for IL-4, IFN?, IL-17, ROR?t, and 
T-bet. The housekeeping gene ?-actin was used as an internal control. 
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Figure 2-7.  Intracellular cytokine staining showing percentage of Th1 and Th17 
cells in the lungs following 3 weeks of SR exposed mice. 
 
Mice (n=5) exposed to100?g SR for three weeks, then lung cells were isolated and 
stimulated in a 96 well plate (5x105 cells/well) ex vivo either with media or 20?g SR 
lysate for 3 hours followed by 3 hours of golgi plug at 37°C to accumulate cytokines 
inside the cell. Cells were stained for CD45, CD4, IL-17, and IFN?????? Representative 
flow cytometry dot plot of IL-17 and IFN? expression by intracellular cytokine staining 
showed an increase in Th17 cells from the lungs of SR exposed mouse following SR ex
vivo stimulation. (B) ?verage percentage of Th1, Th17, and IFN??/IL-17+ CD4+ T cells. 
Results were expressed as means ±SD. One way ANOVA followed by Tukey’s post 
ANOVA test was used to compare means of all groups. (***P<0.0001.) 
  
(A) 
(B) 
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Characterization of BALF during Chronic HP 
The previous results suggested that a predominant Th17 response was associated 
with granulomatous HP; however, this phase resolves and the lung returns to normal if 
the exposures are stopped (Fitzpatrick unpublished data). During the chronic form of HP, 
the granulomas become fibrotic and the disease does not resolve even if the exposures are 
stopped. This form of HP is associated with significant morbidity and mortality. To 
determine if the Th17 response is associated with this more severe phase or if the disease 
has switched to become more of a Th2 or Th1 response, we examined the T cell response 
following chronic exposure to SR. First, we characterized the compostion of BAL cells 
during the chronic phase of HP. Following 25 weeks of SR exposure, mice developed 
alveolitis which was mainly composed of neutrophils showing neutrophil influx during 
the chronic phase. Neutrophils represent 75% of the total cell in the airways compared to 
1.25% in the unexposed mice. For T cells, there was an increase in the percentage of total 
T cells where CD4+ T cells constituted 50% of total T cells. Although, the percentage of 
NK cells in the BAL of  unexposed mice is higher than exposed mice, their  actual 
numbers  are aproximately equal. Finally, there was not an increase in the percentage of 
CD8 T cells but the actual numbers of CD8+ T cells higher in the WT exposed mice 
compared to unexposed mice (Table 2-5). 
 
 
Chronic HP Is Associated with Granuloma Formation 
 
We analyzed granuloma formation during the chronic phase of the disease and 
found the granulomas were still located in the peribronchiolar region. As shown in 
Fig. 2-8, following 25 weeks of SR exposure, there was peribronchiolar granuloma 
formation as shown by H&E staining. 
 
 
Chronic HP Is Associated with Activated CD4+ and CD8+ T Cells 
 
To identify the immune cells infiltrating the lungs during chronic HP, we 
performed cell surface flow cytometry. Mice were exposed to SR for 25 weeks and the 
lung cells were isolated and incubated with fluorochrome conjugated antibodies to CD45, 
NK1.1, Gr-1, CD4, CD8, TCR? chain, CD69 and CD25. 
 
As observed in the granulomatous HP, the results demonstrated a significant 
decrease in the percentage of lung NK cells in the exposed mice compared to unexposed 
mice (9.2% ±1.8 Vs. 3.1% ±0.8). We also found a signficant increase in the percentage of 
neutrophils in SR exposed mice (14.7% ±2.6) compared to unexposed mice (6% ±1.4) 
suggesting a pathogenic role at that stage of the disease. Furthermore, T cells represent 
(28% ±4.5) of the total immune cells in the lungs compared to 17% ±3.19 in unexposed 
mice. CD4+ T cells represent 18% ±3.4 of the total T cells in the lungs of mice following 
chronic SR exposure while CD4+ T cells represent 9% ±2.7 of the total lung T cells of 
controls. The activation marker CD69. SR exposed mice showed a signficant increase in 
the percentage of CD4+/CD69+ T cells compared to unexposed mice (11% ±3 Vs. 2.7% 
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Table 2-5. Characterization of BAL cells during chronic HP. 
Mice Alveolitis
a 
(±SD) 
PMN b 
%(±SD) 
NK 
cellsb 
%(±SD) 
T cells b 
%(±SD) 
CD4 T 
cells b 
%(±SD) 
CD8 T 
cells b 
%(±SD) 
Unexposed 
C57BL/6J 
0.65x106 
(±0.37) 
1.25 
(±1) 
28.21 
(±13.1) 
3.6 
(±0.98) 
2.66 
(±0.58) 
1.75 
(±0.41) 
SR 
Exposed 
C57BL/6J
5.82x106 
(±3.2)*** 
75.6 
(±6.6)*** 
3.45 
(+/-0.73) 
8.4 
(±3.39)** 
4.6 
(±2.1)** 
2.52 
(±1.1) 
C57BL/6J mice (n=7-8/group) were exposed to SR (200?g each) three times a week for 
twenty five weeks then sacrificed 4 days following last exposure. 
a BAL was performed and recovered cells were counted using Trypan Blue dye 
exclusion. 
b Cells isolated from the BAL fluid were incubated with antibodies to various cell surface 
markers and analyzed by flow cytometry to determine cellular composition of the BALF. 
PMNs were identified as CD11b+/Gr-1hi. NK cells were identified as NK1.1+ cells. T 
cells were identified as TCR?????CD4 T cells as TCR???CD4+, and CD8 T cells as 
TCR??/CD8+. Results were expressed as means ±SD. Unpaired student’s t-test was used 
to compare the mean of both groups. (??P<??????and ???P????????significant 
difference?from the unexposed group.) 
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Figure 2-8.  Peribronchiolar granuloma formation following 25 weeks of SR 
exposure.  
 
Following 25 weeks of SR exposure, C57BL/6J mice were sacrificed and one lung lobe 
was used for H&E. By staining lung sections from unexposed or SR exposed mice, we 
showed granuloma formation in the exposed mice (Original magnification 63X). Panel A 
represents lung section from unexposed mouse. Panel B represents lung section from SR 
exposed mouse following 25 weeks of SR exposure. 
A B 
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±1.7). Also, there was a signficant increase in CD4+/CD25+ T cells in SR exposed mice 
compared to unexposed mice (3% ±0.8 Vs. 1.25% ±0.6). Although there was not a 
significant diffenerce in the percentage of CD8+ T cells between unexposed and exposed 
mice, we found a signficant increase in the percentage of activated CD8+ T cells 
comapred to unexposed mice (3.3% ±1.2 Vs. 0.6% ±0.2) (Fig. 2-9). In conclusion, these 
results demonstrated that chronic HP is associated with neutrophils, activated CD4+ and 
CD8+ T cells in the lungs. 
Chronic HP Is Associated with a Th17 Immune Response 
Since the chronic phase of the disease is associated with fibrosis, it is important to 
identify the type of immune response that contributes to disease severity. We examined 
the T cell response following chronic exposure to SR to determine whether the influx of 
activated T cells into the lungs of exposed mice was composed of Th1, Th2, or Th17 
cells. We used semi-quantitative RT-PCR to measure the expression of T cell 
differentiation factors and cytokines. Total RNA was isolated from the individual lung 
lobes of mice exposed to SR for 25 weeks. Semi-quantitative RT-PCR was performed 
using primers specific for Th1 cytokine IFN? and Th1transcription factor T-bet, the Th2 
cytokine IL-4, Th17 cytokine IL-17 and Th17 transcription factor ROR?t.  The results 
demonstrated faint bands for IL-4 in 2/5 mice exposed to SR suggesting there was not a 
switch to a Th2 response at this time point. There was an increase in IFN?? mRNA in the 
exposed mice compared to unexposed mice; however, mRNA for the Th1 transcription 
factor T-bet was not increased at this time point.  Both IL-17 and the Th17 transcription 
factor ROR?t were increased suggesting that a Th17 response was maintained throughout 
this stage of the disease (Fig. 2-10). 
 
The upregulation in IL-17 and ROR?t mRNA levels in the lung homogenates 
suggested that Th17 cells had migrated into the lungs following SR exposure. In order to 
measure the level of Th1 and Th17 cells in the lungs, we performed intracellular cytokine 
staining. Mice were exposed to SR for 25 weeks and then lung cells were isolated 
followed by ex vivo overnight stimulation with media or SR in presence of activated 
adherent spleen cells. Flow cytometry was performed using antibodies against CD4, 
TCR? chain (cell surface staining), IL-17 and IFN? (intracellular staining). 
 
Following ex vivo stimulation with SR, or media, there was a significant increase 
in the percentage of Th17 cells compared to Th1 and IFN?+/IL-17+ CD4+ T cells in the 
lungs of SR exposed mice (Fig. 2-11). In conclusion, these data indicated that a 
predominant Th17 immune response is associated with HP during its chronic stage 
suggesting a pathogenic role for Th17 response during HP. 
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Figure 2-9.  Cell surface staining showing the average percentage of different cell 
populations in the lung interstium of unexposed and SR exposed mice following 
25 weeks of SR exposure. 
 
Lung cells were isolated from unexposed mice (n=7-8) and mice exposed to150?g SR for 
twenty five weeks. Cells were incubated with CD45, Gr-1, NK1.1, TCR?, CD4, CD8, 
CD69, and CD25. Data was acquired on LSRII using FACS Diva Software. 
Approximately 20,000 events were collected. Cells were gated as follows for NK cells 
CD45+/NK1.1+, PMNs CD45+/CD11b+/Gr-1hi , T cells  CD45?/TCR?+, CD4 T cells 
CD45+/TCR?+/CD4+, activated T cells as CD45+/TCR?+/CD4+ or CD8+/CD69+ or 
CD25+. Results were expressed as means ±SD. Unpaired student’s t-test was used to 
compare mean of both groups. (***P<0.001, significant difference?compared to 
unexposed group.) 
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Figure 2-10.  mRNA expression of different cytokines and T cell transcription 
factors from unexposed and SR exposed mice during chronic HP.  
 
C57BL/6J mice (n=5) were exposed to150?g SR for 25 weeks. Unexposed mice were 
used as control. Total RNA was extracted from one lung lobe of individual mice and 
reverse transcribed into cDNA for RT- PCR using primers specific for IL-4, IFN?, IL-17, 
ROR?t, and T-bet. The housekeeping gene ?-actin was used as an internal control. 
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Figure 2-11. Intracellular cytokine staining showing percentage of Th17 and Th1 
cells in the lungs following 25 weeks of SR exposure. 
 
Lung cells were isolated from C57BL/6J unexposed mice (n=3) (used as a control) and 
mice exposed (n=4) to 150?g SR for 25 weeks. The cells were cocultured with C57BL/6J 
IFN? activated adherent spleen cells then stimulated ex vivo with media, or 10?g SR at 
37°C for overnight incubation. Cells were stained for CD45, CD4, TCR?, IL-17, and 
IFN?????? Representative Flow cytometry dot plot of IL-17 and IFN? expression from 
CD4+ T cells using intracellular cytokine staining showing increase in Th17 cells from 
the lungs of WT mouse following media, SR or PMA/Ionomycin ex vivo stimulation. (B) 
??verage percentage of Th1, Th17, and IFN?+/IL-17+ CD4+ T cells in the lungs of SR 
exposed mice.  Results were expressed as means ±SD. One way ANOVA followed by 
Tukey’s post ANOVA test was used to compare means of all groups (***P<0.0001). 
  
(B) 
(A) 
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DISCUSSION 
Acute HP: Neutrophilic Alveolitis and IL-17 Expression 
  
The goal of this chapter was to determine the T cell response during HP. We 
hypothesized that HP is associated with the Th17 cell response based on the correlation 
between IL-17 upregulation in the lungs during HP and the neutrophil-rich environment 
which is one of the hallmarks of Th17 response. Our initial studies demonstrated a 
neutrophilic alveolitis during acute HP accompanied by an upregulation in mRNA 
expression of CXCL2 and IL-17. This experiment was only showing the correlation 
between expression of IL-17 and CXCL2 and neutrophil recruitment; however, the direct 
effect of IL-17 on neutrophil recruitment during acute HP was not tested. Previous data in 
our lab have showed that neutralization of IL-17 over a period of 3 weeks of SR exposure 
decreased significantly the influx of neutrophils into the airways compared to control 
mice. In summary, the data demonstrated the relation between IL-17 and CXCL2 
expression and neutrophilic alveolitis during acute HP. 
The previous data indicated that the initial response during acute HP is inclined 
towards a Th17 cell response later on during adaptive phase of HP. However, further 
experiments are required to prove this statement. Therefore, we measured the cytokines 
associated with a Th17 immune response as well as cytokines required for Th17 cell 
differentiation during acute HP. Using semi-quantitative RT-PCR, we identified an 
upregulation in IL-6 while IL-21, IL-22, and IL-23 were detected but weakly expressed. 
Since IL-6 is required for Th17 differentiation; therefore, the upregulation in IL-6 might 
indicates a progression to Th17 cell development later on in the disease. The expression 
of IL-23 at that stage of HP might be required for induction of IL-17 from other innate 
cells e.g. ?? T cells and NKT cells [160]. As mentioned in the introduction, IL-22 plays a 
protective role at mucosal surfaces against bacterial infections through induction of 
several mechanisms e.g. induction of antimicrobial peptides, enhancement of barrier 
integrity. Although, it was reported that IL-22 plays a protective role against development 
of fibrosis during HP, its role during acute HP was not addressed. In conclusion, these 
results mean a probable Th17 response later on during adaptive stages of HP 
(granulomatous and chronic HP). 
 
 
Granulomatous HP and the Th17 Response 
  
The detection of IL-6, IL-21, IL-22, and IL-23 during acute HP suggested that a 
Th17- associated micro-environment developed after exposure to SR. Therefore, we 
wanted to determine whether a Th17 immune response was present during the 
granulomatous phase of the disease and so we examined mice that had been exposed to 
SR for 3 weeks. The results demonstrated a lymphocytic alveolitis during granulomatous 
HP rather than neutrophilic, where CD4+ T cells constituted a large percentage of T cells. 
As mentioned earlier in the introduction, CD4+ T cells play a pathogenic role in HP. 
Also, they are required for granuloma formation. Therefore, the presence of CD4+ T cells 
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in the airways indicated their pathogenic role in the lungs. Since H&E staining showed 
that granulomatous HP was associated with peribronchiolar granuloma, we measured the 
phenotype of the T cells in the lung. As expected we found an increase in the percentage 
of total T cells and the CD4+ T cells were activated as compared to unexposed mice 
although the difference did not reach the level of statistical significance. By using only 
3 mice per group, the statistical analysis was underpowered. The presence of activated 
CD4+ T cells in the lungs suggested that the T cells encountered SR antigen presented by 
APCs in the lungs. Also, it indicated that T cells are secreting their effector cytokines and 
their interaction with APCs activates APCs to secret cytokines that contribute to lung 
pathology. Also, there was no difference in the percentage of PMNs isolated from the 
lung between unexposed and SR exposed mice. Since the mice were sacrificed 4 days 
after last exposure, that might explain why we found low percentage of PMNs in the 
lungs. The PMNs were recruited shortly after SR exposure then they died later on, while 
the T cells remained activated because they encountered SR antigen in the lungs 
presented by APCs. Finally, there was a signficant decrease in the percentage of NK cells 
in the lungs of exposed mice compared to unexposed mice. NK cells could be 
outnumbered by recruitment of other cell populations in the lungs. In conclusion, these 
results suggested that during granulomatous HP, granuloma formation is associated with 
activated CD4+ T cells. 
Next, we wanted to examine the type of the CD4+ T cells in the lungs, whether 
Th1, Th2, or Th17 developed during granulomatous HP. Using semi-quantitative 
RT-PCR, we found an upregulation in the Th17 transcription factor, ROR?t and Th17 
signature cytokine, IL-17 suggesting that Th17 cells were present in the lungs and the 
presence of IL-17 suggested that they are actively secreting IL-17. There was an increase 
in the Th1 cytokine IFN? but no increase in the transcription factor T-bet which indicated 
that the increase in IFN? was not from Th1 cells, but it could be from another type of cell. 
Previous results from our lab showed that neutrophils are an important source of IFN? 
during HP [129]. Finally, we did not detect a significant upregulation of IL-4 in the 
exposed mice as compared to the unexposed mice demonstrating that a Th2 response had 
not developed. The absence of Th2 response during HP indicated that induction of 
fibrosis during chronic stage is attributed to a different T cell response other than Th2 
response; however, we still need to examine the T cell response during the chronic stage 
to reach to this conclusion. Since the cytokine profile present in the lung suggested both 
Th17 cells as well as Th1 cells (IFN? production), we measured the level of SR antigen 
specific Th1 and Th17 cells in the lungs using intracellular cytokine staining. We found 
that SR antigen specific Th17 cells were the dominant effector T cells in the lungs after 
3 weeks of SR exposure while SR antigen specific Th1 represented a small percentage 
which is confirmed by PCR results. The presence of Th17 cell response in the lungs 
associated with granuloma formation suggested to us that these cells could play a role in 
the pathogenesis of HP during this stage. One study demonstrated the association of Th17 
response with granuloma formation. Mouse infection with schistosome egg antigen with 
Complete Freund’s Adjuvant (SEA/CFA) resulted in granuloma formation accompanied 
by Th17 response. In conclusion, Th17 cells were associated with granuloma formation 
during granulomatous HP suggesting their pathogenic role during HP. 
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Chronic HP and Th17 Response 
The next stage of our studies was to determine if the Th17 cell response was 
associated with the chronic phase of the disease or if the response switched to a Th1 or 
Th2 response. This is important since the chronic response is associated with fibrosis and 
significant morbidity and mortality. We exposed mice to SR for 25 weeks and measured 
several parameters of disease severity. The results demonstrated a neutrophilic alveolitis 
with an increase in the number of T cells specifically CD4+ T cells, in exposed mice 
compared to unexposed mice. These results were not surprising since neutrophils produce 
mediators such as collagenases and gelatinases that cause tissue remodeling and fibrosis 
which is the hallmark of chronic HP [113]. The increase in CD4+ T cells which reflected 
to us their presence in the lung was also expected, since we found chronic HP was 
associated also with granuloma as in the granulomatous phase using H&E staining. To 
identify the cellular composition of the interstitial lung cell population during chronic 
HP, we harvested the lungs after 25 week of chronic exposure protocol and performed 
flow cytometry. We identified an increase in the percentage of lung neutrophils following 
SR exposure compared to unexposed mice. In chronic HP patients, neutrophils express 
gelatinases and collagenases which might contribute to fibrotic response during chronic 
HP [113]. We also found that T cells represent the largest population in the lungs of 
exposed mice especially activated CD4+ T cells and CD8+ T cells. The presence of 
activated CD4+ T cells suggested that T ells encountered SR antigen in the lungs 
presented by APCs and the activated CD4+ T cells are producing effector cytokines. 
Although CD4+ T cells are the pathogenic T cells in HP, we had found activated CD8+ 
T cells during chronic HP. Previous studies in our lab demonstrated that CD8+ T cells do 
not produce IL-17. These results suggested that during chronic HP, granuloma formation 
is associated with activated CD4+, CD8+ T cells, and neutrophils.  
To determine the type of activated CD4+ T cell whether Th1, Th2, or Th17; we 
used semi-quantitative RT-PCR. Following 25 weeks of SR exposure, we found an 
upregulation in the Th17 transcription factor (ROR?t), IL-17 and IFN? without change in 
T-bet and IL-4 expression in SR exposed mice suggesting presence of both Th1 and 
Th17 cells and the absence of Th2 cells at that stage. The absence of Th2 cells indicated 
that the fibrosis process in that model is mediated by another type of T cells presumably 
by Th17 cells. Since the cytokine profile present in the lung suggested that both 
Th17 cells as well as Th1 cells (IFN? production) were present, we measured the level of 
SR antigen specific Th1 and Th17 cells in the lungs using intracellular cytokine staining. 
The results demonstrated that SR antigen specific Th17 cells are still the 
dominant effector T cells in the lungs after 25 weeks of SR exposure while SR antigen 
specific Th1 represented a small percentage. Th17 cells could be contributing to the 
fibrosis process during chronic HP through production of IL-17 as an effector cytokine. 
IL-17 consequently induces neutrophil recruitment into the lungs which is already 
observed during chronic HP. Finally, neutrophils might play a role in fibrosis through 
secretion of gelatinases and collagenases that cause tissue remodeling and eventually 
fibrosis [113]. In conclusion, Th17 cells might play an indirect role in fibrotic response 
possibly through neutrophil recruitment during chronic HP. 
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IFN??/IL-17+ CD4+ T cells were only observed following PMA/Ionomycin and 
they were absent following ex vivo media and SR stimulation. Th1/Th17 cells can be 
generated from Th17 cells following IL-12/IFN? stimulation [171], hence, 
PMA/Ionomycin might be stimulating IL-12 and IFN? production that can switch Th17 
response to Th1/Th17 response. The origin of the double producers is not clear but there 
have been several studies addressing this issue. Hirota et al. demonstrated that the double 
producers originally derived from Th17 cell [172]. Since these cells were enriched in 
target organs of several autoimmune diseases, it was suggested that these cells were 
pathogenic; whether these cells were pathogenic or protective it was not shown clearly in 
the literature [173]. 
 
 
Th17 Response and HP: A Correlation Not a Cause and Effect Study 
 
Our results from this chapter demonstrated a correlation between disease severity 
and Th17 response. The role of Th17 cells in HP still remains to be answered. Simonian 
et al. demonstrated that reconstitution of TCR?/? DKO mice (mice lacking CD4+, CD8+, 
and ?? T cells) with splenic naïve CD4+ T cells followed by SR exposure for 4 weeks 
resulted in lung inflammation and increase in lung collagen content as a measurement of 
fibrosis. This coincided with an increase in IL-17 expression in the lung homogenates 
compared to those mice exposed to PBS. These data demonstrated the importance of 
CD4+ T cells as inducers of lung inflammation and fibrosis during HP in a direct or 
indirect way. Furthermore, repeated exposure of WT mice to SR for 4 weeks increases 
the frequency of Th17 in the lungs [62]. To identify the role of  IL-17 in HP Simonian et
al. and Joshi et al used IL-17RKO and IL-17KO mice and exposed them to SR [62, 174]. 
Both studies demonstrated a significant reduction in lung inflammation [62, 174] and 
collagen deposition in IL-17R knockout exposed mice compared to WT exposed mice 
[62]. Even though IL-17 is one of the signature cytokines of Th17, it is still produced by 
other immune cells [157-159]. Adoptive transfer experiment could be performed to 
investigate the direct role of Th17 during HP. In this experiment, Th17 cells from SR 
exposed mice will be adoptively transfered into TCR?/? DKO mice followed by SR 
exposure then lung inflammation and collagen content will be tested. In summary, the 
authors concluded from their data that Th17 plays a pathogenic role of Th17 during HP 
[62]; yet, how these cells cause lung fibrosis remains to be an open question. 
 
Our results demonstrated an increase in IL-22 in the lungs following SR exposure. 
The role of IL-22 in lung fibrosis was previously addressed during HP by Simonian et al. 
[175]. In a HP mouse model caused by B. subtilis, IL-22 is produced mainly by a subset 
of ???T cells. IL-22 expression from ?? T cells requires stimulation of the Aryl 
hydrocarbon receptor (AhR) by environmental toxins [176]. In B. subtilis mouse HP 
model, AhR mutant mice (AhRd/d) are characterized by reduced IL-22 expression by ???T 
cells along with increase in collagen deposition [175]. To confirm these data, 
recombinant IL-22 was injected into (AhRd/d) mice and TCR?KO mice exposed to 
B. subtilis causing reduction in collagen content as well as reduced lung CD4+ T cell 
recruitment and lung inflammation. In the same line of evidence, neutralization of IL-22 
in WT mice exposed to B. subtilis for 4 weeks resulted in an increase in the amount of 
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collagen and the number of CD4+ T cells in the lungs compared to mice treated with 
isotype antibody [175]. Taken together, these data suggest that IL-22 plays a protective 
role in the B. subtilis induced HP model. In Farmer’s Lung disease model, the frequency 
of CD4+ T cells expressing IL-22 in lungs is low [62] and IL-22 produced by ?? T cells 
during B. subtilis induced HP is protective [175]. Although both models are induced by 
different agents, a correlation can be drawn from these two studies.  The low expression 
of IL-22 in Th17 cells during HP might be contributing to the disease severity. In 
conclusion, we hypothesized that HP is a Th1/Th17 mediated disease, yet the 
contribution of each subset to disease severity is still enigmatic. Several experimental 
disease models showed the coexistence of both Th1 and Th17 cells during the disease 
progression. In the T. cruzi mouse infection model, a Th1 response develops upon antigen 
challenge as well as a strong Th17 response [170]. In experimental autoimmune uveitis as 
a model for human uveitis, either Th1 or Th17 cells can cause the disease [177]. 
Furthermore, in experimental autoimmune encephalomyelitis (EAE), both Th1 and Th17 
cells infiltrate the CNS [178] and antigen specific Th1 or Th17 cells generated in vitro 
adoptively transfer the disease into naïve mice [179]. Thus, all the previous studies 
showed the coexistence of Th1 and Th17 in different diseases. The cooperation between 
both types of T cells was demonstrated in EAE model when Th1cells collaborate with 
Th17 cells by facilitating the entry of Th17 into CNS [180]. In summary, our results from 
this chapter demonstrated a predominant Th17 response with low percentage of Th1 cells 
during granulomatous and chronic HP.  
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CHAPTER 3.   T-BET IN HP* 
The results from chapter 2 indicated that both granulomatous and chronic HP are 
associated with a predominant Th17 response. However, HP was considered as 
Th1-mediated disease, since IFN??was required for granuloma formation during HP. In 
order to clarify the role of IFN? in the disease, we examined the regulation more closely. 
In this chapter, we will identify the cytokines required for IFN? production from 
neutrophils, determine role of T-bet in the regulation of Th17 development and disease 
severity. The results demonstrated that combination of IL-12/ IL-18 or IL-15/IL-18 were 
required for induction of IFN? from neutrophils and T-bet inhibits Th17 response and 
controls disease severity during HP. 
 
 
INTRODUCTION 
 
T-bet (T-box expressed in T-cells) is the master transcription factor required for 
Th1 differentiation ???. Although the name suggests that it is expressed by T cells only, 
other immune cells such as dendritic cells [9], NK, and NKT cells [10] can express it as 
well. During Th1 polarization, the expression of T-bet in naïve T cells is induced by the 
synergistic effect of TCR stimulation and IFN??STAT1 signaling. Induction of T-bet 
induces expression of the IL-12R?2 subunit on the cell surface increasing responsiveness 
of the cell to IL-12. With additional IL-12 stimulation more T-bet is induced resulting in 
amplification of the reaction. T-bet also induces an array of genes such as IFN?, CCL4, 
CCL3 and CXCR3 (chemokine receptor for CCL3 and CCL4). Since these chemokines 
are important for Th1 cell migration T-bet indirectly contributes to Th1 cell recruitment 
to sites of inflammation [181]. Although, IFN? is the prototypic cytokine produced by 
Th1 cells, other immune cells, such as CD8+ T cells, NK cells, NKT cells, antigen 
presenting cells and neutrophils [182-184] can express it as well. Neutrophils are 
considered as an important source of IFN??during HP [129]; however, it is not known 
how IFN?? expression is induced in neutrophils and whether T-bet is expressed by 
neutrophils is still unclear. Several cytokines have been reported to stimulate IFN? from 
neutrophils including IL-12 alone or in combination with IL-2, IL-15, IL-18, or LPS. The 
combination of IL-12 with IL-15 was the most efficient at inducing IFN? production from 
human neutrophils [183]. In a different study neutrophils isolated from human uterine 
endometrium tissue were able to produce IFN? upon stimulation with a combination of 
TNF? and IL-12 [182]. Finally, peritoneal murine neutrophils produced IFN? following
stimulation with LPS [185]. In this chapter we will identify the cytokines that induce 
IFN? production from neutrophils isolated from SR exposed mice.  
 
Regulation of IFN? production and Th1 differentiation is not the lone function of 
T-bet. T-bet can also inhibit Th2 differentiation by binding to GATA-3 (a Th2 
transcription factor) and hence sequester GATA-3 from binding to IL-5 and IL-13 
 
*(Adapted with permission from Abdelsamed, H.A., et al., T-bet controls severity of 
hypersensitivity pneumonitis. J Inflamm (Lond), 2011. 8(1): p. 15 [186].) 
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promoters. T-bet also binds to Runx-3 transcription factor and both bind to the IL-4 
silencer to inhibit IL-4 expression [181]. Recently, Lazarevic et al. showed that T-bet 
binds to Runx-1 transcription factor inhibiting the expression of Th17 specific 
transcription factor ROR?t expression and hence ROR?t target genes expression e.g. 
IL-17a, IL-17f, and IL-23r [187] (Fig. 3-1). Therefore, the expression of T-bet during the 
development of HP may not only influence the development of a Th1 response but also a 
Th2 and Th17 response. In this chapter we will identify whether a deficiency in T-bet 
results in the development of a Th2 or Th17 response in HP and how that affects 
granuloma development and fibrosis. 
 
The role of T-bet in different infectious and organ specific autoimmune disease 
models has been addressed in several studies [188-196]. Since Th1 cells are important for 
clearance of intracellular pathogens and T-bet is required for Th1 differentiation, deletion 
of T-bet in mice renders them susceptible to a wide range of intracellular pathogens e.g. 
Mycobacterium tuberculosis [188], Leishmania major [195], Staphylococcus aureus 
[189], and Salmonella typhimurium [190]. However, T-bet also may play a role in 
autoimmune diseases. T-bet KO mice are resistant to the development of several 
autoimmune diseases e.g. experimental autoimmune encephalitis (EAE) [191, 196], 
arthritis [192], and type I diabetes [193, 194]. Furthermore, T-bet KO mice infected with 
S. mansoni showed increase in disease severity accompanied by increase in Th17 
cytokines [169]. Additionally, in T. cruzi mouse infection model there was an increase in 
the percentage of Th17 cells from the spleens of T-bet KO mice [170]. Several studies 
demonstrated the role of T-bet in fibrosis. T-bet KO mice treated with bleomycin showed 
an increase in lung and skin collagen content compared to WT mice [64, 65]. The goals 
of the studies are to determine the cytokines required for IFN? expression from 
neutrophils during HP and the effect of T-bet on disease severity and Th17 response 
during HP. 
 
 
MATERIALS AND METHODS 
 
 
Animals 
 
Female C57BL/6J WT and T-bet KO mice were purchased from Jackson 
Laboratories (Bar Harbor, ME) and used in experiments between 6-10 weeks of age. 
Sterile micro-isolator cages with sterile food and water ad libitum were used for animal 
housing. All the protocols were approved by the Institutional Animal Care and Use 
Committee (IACUC), the University of Tennessee Health Science Center. All animals 
were maintained by the Division of Comparative Medicine at the University of Tennessee 
Health Science Center according to the guidelines of the animal welfare act. 
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Figure 3-1. Role of T-bet in differentiation of different subsets CD4+ helper T 
cells. 
In Th1cells, T-bet induces IFN?, CXCR3, CCL3, CCL4, and IL-12R?2 gene expression. 
T-bet inhibits Th2 differentiation by sequestering GATA-3 from binding to its specific 
promoters. T-bet inhibits differentiation of Th17 through binding to transcription factor 
Runx-1 inhibiting expression of ROR?t. (Adapted with permission Lazarevic, V. and 
L.H. Glimcher, T-bet in disease. Nat Immunol, 2011. 12(7): p. 597-606 [181].) 
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Spleen Cell Isolation and Stimulation 
Single cell suspension from spleen was prepared by digesting spleen tissue in a 
Stomacher® 80 tissue processor. RBCs were lysed and the cell suspension was washed 
with sterile PBS. In a 96-well plate, 5x105 cells/well were stimulated with media alone, 
5?g lyophilized SR, 5?g lyophilized SR in the presence of anti-IL12p40 (10?g/ml), 
anti-IL-15 (10?g/ml), anti-IL18 (10?g/ml) individually or in combination. After 24 
hours, culture supernatants were collected to measure IFN? concentration using ELISA.  
 
 
Neutrophil Cell Sorting and Stimulation 
 
A cell sorter (BD FACSAria) was used to sort lung neutrophils from C57BL/6J 
mice. Mice were exposed to 225?g SR one time; and sacrificed 18 hours post-exposure. 
A single cell suspension of lung cells was prepared and the cells incubated with 
fluorchrome labeled antibodies to the following cell surface markers: CD45, CD11b, 
Gr-1, and NK1.1. Neutrophils were sorted as (CD45+/CD11b+/Gr-1hi /NK1.1-) and plated 
at 7.5x105cells/well in a 96-well plate.  The cells were stimulated with IL-12 (10ng/ml), 
IL-18 (20ng/ml), and or IL-23 (20ng/ml) individually or in combination. After overnight 
incubation, the culture supernatants were collected to measure IFN? concentration by 
ELISA. 
 
 
RNA Extraction and Real-Time PCR 
 
RNA Extraction 
 
Total RNA was extracted from one lung lobe from individual mice using Trizol 
(Invitrogen, Carlsbad, CA). Contaminating genomic DNA was removed by treating the 
RNA samples with DNase (Turbo DNA free, Ambion, Austin, TX). RNA concentration 
was determined by measuring the absorbance of UV light at 260nm, and 280nm using 
Ultrospec 2000 spectrophotometer (Pharmacia Biotech, Piscataway, NJ). The 
concentration of RNA (μg/ml) was calculated by multiplying the absorbance (A260), the 
dilution factor and 40μg/ml. 
 
To determine the quality of the RNA 1-2?gs were loaded on a 4% agarose gel and 
analyzed for the presence of 18S and 28S ribosomal RNA subunits as indicator of intact 
RNA. 
 
Real-Time PCR 
 
One ?g of RNA was reverse transcribed into cDNA using Transcriptor First 
Strand cDNA synthesis kit (Roche Applied Science, Indianapolis, IN). Each PCR cycle 
was run using a LC480 light cycler with and activation step at 95oC for 5 minutes, 
denaturation at 94°C for 10 sec, annealing for 30 seconds at 60oC and extension at 72oC 
for 10 seconds. The reaction was amplified for 50 cycles. The housekeeping gene HPRT 
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was used to normalize mRNA levels and ??ct method was used to calculate fold increase 
over the unexposed controls. All primers and probes were chosen from online software 
Universal Probe Library available at <http://www.roche applied 
science.com/sis/rtpcr/upl/index.jsp>. 
 
 
Histology 
 
The perfused left lung lobe was harvested and fixed overnight in neutral buffered 
formalin at 4oC. The lung tissue was embedded in paraffin and sectioned into 8 ?m 
sections and stained with Hematoxylin and Eosin (H&E) by the Department of 
Pathology, UTHSC. 
 
 
Measurement of Lung Collagen Content 
 
The Sircol™ Collagen Assay (Biocolor Ltd., UK) was performed to measure 
collagen in the lungs of individual mice per manufacturer’s instructions. The right lung 
lobe was homogenized in 0.5M acetic acid containing protease inhibitors and incubated 
for 24 hours at 4°C with shaking to extract acid soluble collagen. One ml of the 
homogenate was centrifuged at 15000xg for 1 hour and the supernatant removed and 
clarified by passage through a 0.22?m syringe filter. The standard curve was prepared 
from the collagen stock solution (1mg/ml) using 2-fold serial dilutions in deionized water 
The samples and standards were added to 1ml of sircoll dye followed by incubation at 
room temperature for 30 minutes with shaking. Following centrifugation at 10,000xg for 
10 minutes, the unbound dye was aspirated and 1 ml of alkali solution was added. Two 
hundred ?l was transferred to a 96-well plate and absorbance at 550nm recorded. The 
concentration of the unknowns was calculated from the standard curve. 
 
 
Statistical Analysis 
 
Values were expressed as mean ±S.D. For comparison of means between two 
populations of unpaired data, unpaired student’s t-test was used. For comparison between 
more than two groups, One-way ANOVA followed by Tukey’s post ANOVA test was 
used. GraphPad Prism was used to perform all tests. Differences were considered 
significant at P <0.05. 
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RESULTS 
 
 
Regulation of IFN? during HP 
 
Neutralization of IL-12p40 Inhibits IFN? Production from S. rectivirgula Stimulated 
Spleen Cells 
 
Previous studies in our lab showed that neutrophils are the main source of 
IFN??following SR exposure [129]; however, it was unknown whether SR could induce 
IFN??directly or indirectly through induction of cytokines that stimulate IFN??production 
e.g. IL-12, IL-15, IL-18, and IL-23. Spleen cells were isolated from C57BL/6J mice and 
then stimulated with SR alone or in the presence of anti-IL-12p40 antibody (will 
neutralize both IL-12 and IL-23), anti-IL-15 antibody, and anti-IL-18 antibody 
individually or in combination. Twenty four hours later, culture supernatants were 
collected for measurement of IFN? using ELISA. As shown in Fig. 3-2, SR stimulated 
IFN? production from spleen cells and this stimulation was unaffected by the addition of 
antibody to IL-15 or IL-18 suggesting they do not play a role in SR stimulation of IFN?. 
However, SR stimulation of IFN? was inhibited by neutralization of IL-12p40 alone or in 
combination with the other antibodies. This data suggested that SR mediates induction of 
IFN? from spleen cells via IL-12 and/or IL-23 since both cytokines share the IL-12p40 
chain. 
 
IL-12/IL-18 Combination but not IL-23 Combination with IL-12 or IL-18 Induces IFN? 
from Neutrophils 
 
Previous studies in the lab had suggested that IL-18 in combination with IL-15 or 
IL-12 was able to stimulate IFN? production from neutrophils. However, the data in the 
previous section suggested that either IL-12 or IL-23 stimulated by SR could induce 
IFN?. Therefore, we wanted to determine whether IL-23 alone or in combination with 
other cytokines could stimulate IFN? production. We sorted neutrophils from the lungs of 
mice exposed to SR one time and stimulated them with IL-12, IL-18, and IL-23 
individually or in combination and measured IFN? production by ELISA. Only the 
combination of IL-12/IL-18 induced IFN? from neutrophils, while IL-23 individually or 
in combination with IL-12 or IL-18 did not (Fig. 3-3). These data suggested that neither 
IL-23 alone nor combination with other cytokines can stimulate IFN? production from 
neutrophils. Only IL-12 in combination with IL-18 can stimulate IFN? from neutrophils. 
 
Role of IL-18 and T-bet in IFN? Production 
 
Since our previous studies demonstrated that IL-18 in combination with either 
IL-12 or IL-15 stimulated IFN??from sorted neutrophils significantly more than any other 
combination, it suggests that IL-18 is critical for neutrophil IFN? production.  
Additionally, IL-18 stimulates IFN? through T-bet [197]. We hypothesized that SR uses 
the transcription factor T-bet for IFN? production. To test this hypothesis, spleen cells 
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Figure 3-2. SR induces IFN? from spleen cells indirectly through cytokines. 
 
Spleen cells isolated form C57BL/6J mice (n=4) were stimulated for 24 hours with SR 
(5?g) alone or in the presence of anti-IL-12p40 antibody (10?g/ml), anti-IL-15 antibody 
(10?g/ml), anti-IL-18 anitbody (10?g/ml) individually or in combination. Culture 
supernatants were collected and IFN? was measured by ELISA. Data were expressed as 
means ± SD. All cytokine combinations compared to each other using one way ANOVA 
followed by Tukey’s post ANOVA test. (*P<0.05 and **P<0.01 significant difference 
from spleen cells stimulated with SR.) 
 
  
54 
Figure 3-3. Neither IL-12 nor IL-23 alone stimulates IFN? production by 
neutrophils. 
 
Neutrophils (CD45+/CD11b+/Ly6G+/NK1.1-) were sorted from the lungs of mice exposed 
one time with 225?g SR then sacrificed18 hours post SR exposure. The neutrophils were 
stimulated with IL-12, IL-18, IL-23 individually or in combinations for 18 hours 
approximately. Culture supernatants were collected and IFN? was measured using 
ELISA. Data were expressed as means ± SD. Using unpaired student’s t-test, means of 
control media were compared to IL-12/IL-18 induction. (***P<0.0001 significant 
difference from media control group.)  
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from WT or T-bet KO mice were stimulated with SR. Culture supernatants were 
collected after 24 hour of stimulation and IFN? was measured using ELISA. The results 
demonstrated that following SR stimulation WT spleen cells produce a significant 
amount of IFN? compared to T-bet KO spleen cells (Fig. 3-4). These results suggested 
that SR induced IFN??from spleen cell in a T-bet dependent manner. 
Role of T-bet in HP 
T-bet Inhibits Development of the Th17 Response during HP 
The previous section demonstrated the importance of T-bet in regulation of 
IFN??during acute HP. Regulation of IFN? is not the only function of T-bet. It is also 
involved in Th1cell recruitment through upregulation of the chemokine receptor CXCR3 
and chemokines CCL3 and CCL4 [198, 199]. Additionally, T-bet is known to inhibit 
Th17 differentiation [187] and the predominant response during granulomatous and 
chronic HP was the Th17 response. Therefore, we examined the effect of T-bet on 
theTh17 response and disease severity during HP. Following three weeks of SR exposure, 
we found an increase in IL-17 mRNA expression in the lungs of T-bet KO mice 
compared to WT exposed mice. Also, there was a non-significant reduction in IFN? 
mRNA expression (Fig. 3-5). 
 
Since we found an increase in IL-17 mRNA levels in T-bet KO mice, we 
measured IL-17 in BALF from T-bet KO and WT exposed mice using ELISA. Previous 
data in our lab showed an increase in IL-17 protein expression from BALF of T-bet KO 
mice compared to WT mice following three weeks of SR exposure. The upregulation of 
IL-17 mRNA and protein expression led us to determine the frequency of lung Th17 cells 
from T-bet KO and WT exposed mice. Previous studies in our lab showed a significant 
increase in the percentage of Th17 cells from the lungs of T-bet KO mice compared to 
WT exposed mice following ex vivo SR stimulation. In conclusion, these results 
demonstrated the inhibitory effect of T-bet on Th17 development during granulomatous 
HP. 
 
 
Tbet Controls Severity of HP  
 
As demonstrated in chapter 2, Th17 cells were associated with granuloma 
formation as well as the chronic phase of disease. In this chapter we showed an increase 
in the percentage of Th17 cells from T-bet KO exposed to SR. We hypothesized that the 
increase in Th17 cells in the T-bet KO mice would result in an increase in disease 
severity. WT and T-bet KO mice were exposed to SR for 3 weeks and granuloma 
formation in the lungs measured. The results demonstrated an increase in granuloma 
formation in T-bet KO mice exposed to SR compared to WT mice exposed to SR 
(Fig. 3-6). 
 
The increase in granuloma formation in T-bet KO mice exposed to SR suggested 
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Figure 3-4. IFN? production from spleen is T-bet dependent following SR 
stimulation. 
 
Spleen cells were isolated from WT and T-bet KO mice then stimulated with 10?g SR.
Culture supernatant was collected following 24 hours incubation period. IFN??protein 
levels were measured using ELISA? 
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Figure 3-5. Real-time PCR showing expression levels of IL-17 and IFN??in lungs 
of WT and T-bet KO mice following 3 weeks of SR exposure. 
 
Real-time PCR showing expression levels of IL-17 and IFN??in lungs of WT and T-bet 
KO exposed mice. WT and T-bet KO mice were exposed to 150?g SR for three weeks. 
RNA was extracted from one lung lobe then reverse transcribed to cDNA. Real-time PCR 
was performed using primers specific to IL-17 (Panel A) and IFN? (Panel B). Results 
were normalized to the house keeping gene HPRT and expressed as fold induction over 
unexposed mice. Results were expressed as mean ±SD. Using unpaired student’s t-test, 
means of both groups were compared showing a non-significant difference. 
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        WT          T-bet KO 
Figure 3-6. Granuloma formation in WT and T-bet KO mice. 
 
H&E stained lung section from WT and T-bet KO mice exposed to 150?g SR for three 
weeks. (Original magnification 63X). Panel A represents lung section from WT SR 
exposed mouse. Panel B represents lung section from T-bet KO SR exposed mouse. 
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to us there will be an increase in disease severity upon subsequent exposures. Using the 
Sircoll assay we measured collagen content as a measure of fibrosis in the lungs of mice 
exposed to SR for six weeks. The results demonstrated a significant increase in lung 
collagen content from T-bet KO exposed mice compared to WT exposed mice (Fig. 3-7). 
In conclusion, these results suggested that T-bet plays a protective role during HP, 
possibly by limiting Th17 cell generation.   
DISCUSSION 
The pathogenic role of IFN? during HP was addressed by Gudmundsson and 
Hunninghake [128]. They found that IFN? KO (GKO) mice did not develop granulomas 
following SR exposure for 3 weeks compared to WT exposed mice that developed 
granulomas. Furthermore, the replacement of IFN? in GKO mice via intraperitoneal 
injections of IFN? restores back granuloma formation in GKO SR exposed mice [128]. 
Those early studies suggested that the source of IFN? was Th1 cells however, that was 
never proven. Previous studies in our lab did not find a large percentage of Th1 cells 
during HP, rather these studies demonstrated that innate immune cell IFN? production 
was sufficient for disease. Additionally, one of the innate immune cells contributing to 
IFN? production was the neutrophil [129]. However, elucidation of the cytokines required 
for IFN? expression from neutrophils and/or during HP was not addressed. Several 
cytokines can stimulate IFN? from different immune cells and they may function in a 
T-bet dependent or independent manner. IL-2, IL-12, IL-15, IL-18, TNF? as well as LPS 
 
 
 
 
Figure 3-7.  Increased collagen content in the lungs of T-bet KO mice during HP. 
 
C57BL/6J or T-bet KO mice (5/group) were exposed to 150ug SR or saline for six weeks. 
The right lung lobe was removed from mice and collagen content was determined using 
sircoll assay. The results are expressed as amount of collagen/right lobe and represent the 
mean ± SD. Using unpaired student t-test, mean of WT exposed group was compared to 
mean of T-bet KO exposed group. (*P<0.05.) 
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have all been demonstrated to stimulate IFN? from macrophages and neutrophils [182, 
183, 200]. Our results found that neutrophils sorted from SR exposed mice (single 
exposure) produced IFN? in response to IL-18 in combination with IL-12 or IL-15, but 
not to any cytokine alone. It has been reported that alveolar macrophages isolated from 
HP patients produce IL-12 and IL-18 spontaneously without ex vivo stimulation. [114]. 
Therefore, these cytokines produced by AMs might be crucial for production of IFN? 
from neutrophils. In conclusion, the data demonstrated to us the importance of IL-12, 
IL-15, and IL-18 in production of IFN? from neutrophils during HP. 
 
IL-18 can stimulate IFN? expression through T-bet [197], and so we asked 
whether SR induction of IFN? was also through T-bet Spleen cells isolated from a T-bet 
KO mouse did not produce IFN? following  SR stimulation compared to WT spleen cells. 
These results suggested that neutrophil IFN? production may be dependent on T-bet; 
however, we were not successful in our attempts to demonstrate T-bet in neutrophils 
using intracellular staining. One problem with the experiment was not having a strong 
positive control such as a type of immune cells that express high levels of T-bet. A 
separate experiment would be to sort neutrophils from T-bet KO SR exposed mice to 
check the expression of IFN? in the absence of T-bet. In conclusion, the results from 
these studies revealed the importance of T-bet and combination of IL-18/IL-15 or 
IL-18/IL-12 in IFN? regulation during acute HP. 
 
Our studies in chapter 2 found that HP was associated with a Th17 response rather 
than a Th1 or Th2 response. However, there was a small percentage of SR antigen 
specific Th1 cells in the lungs of exposed mice. Previous studies from our lab 
demonstrated that during HP, IFN? produced by Th1 cells is not necessary for granuloma 
formation this raises the question “what is the role of Th1 cells in the disease severity and 
regulation of Th17 response during HP?” To answer this question we used T-bet KO 
mice which lack the ability to mount Th1 cell responses. We exposed WT and T-bet KO 
mice for three and six weeks and examined the Th17 response, granuloma formation, and 
fibrosis in the lungs. We found an upregulation in IL-17 mRNA and protein expression 
following 3 weeks of SR exposure compared to WT exposed mice. In addition, there was 
an increase in the percentage of Th17 cells in the lungs following SR exposure compared 
to WT exposed mice. These results suggested a regulatory effect of T-bet on Th17 cell 
development and expression IL-17 expression. Several disease models demonstrated the 
regulatory effect of T-bet on Th17 effector cytokines. In the S. mansoni mouse infection 
model, T-bet KO mice showed an increase in Th17 cytokines compared to WT infected 
mice [169]. In another parasitic mouse infection model, T-bet KO mice develop a strong 
Th17 response in the spleens compared to WT mice following T. cruzi infection. Also 
there was an increase in the number of neutrophils in the blood [170]. 
 
The increase in Th17 cells during the granulomatous phase of the Tbet KO mice 
suggested to us that the disease was more severe and therefore we examined granuloma 
formation and fibrosis in the WT and T-bet KO mice. As expected following 3 weeks of 
SR exposure we found an increase in granuloma formation in T-bet KO mice compared 
to WT mice although we have not quantified it by measuring the area of the granulomas 
between the WT and Tbet KO groups. Since the morbidity of the disease is due to 
61 
fibrosis, we measured the collagen content in the lungs of WT and T-bet KO mice and 
found an increase in collagen in the T-bet KO mice following 6 weeks of SR exposure. 
Taken together, the shift to stronger Th17 response in T-bet KO exposed mice correlated 
with increase in disease severity. These data suggested two roles for T-bet during HP. 
First, it suggested the protective role of T-bet. Second, the inhibitory effect of T-bet on 
Th17 development; however the exact mechanism by which T-bet inhibits Th17 
development was not clear until recently. Lazarevic et al. showed that T-bet binds to 
Runx-1 transcription factor inhibiting expression of Th17 specific transcription factor 
(ROR?t) and hence its target genes IL-17a, IL-17f, and IL-23r [187]. 
  
The data from these studies demonstrated the role of T-bet in disease severity and 
its effect on Th17 development during HP. Our results do not identify whether T-bet 
expression by an innate or adaptive immune cell is responsible for the inhibition of Th17 
development. The direct experiment to fulfill this aim would require an adoptive transfer 
experiment. WT or T-bet KO CD4+ T cells from naïve mice will be injected into RAG-2 
KO mice. Both groups of mice will be exposed to SR for three weeks (3 days/week). We 
might expect two scenarios. The first scenario, if both groups developed an equal 
percentage of Th17 cells in the lungs, the T-bet expressed by T cells does not play a role 
in Th17 development during HP. The second scenario, if the frequency of Th17 cells is 
more in the group that received T-bet KO T cells than the one received WT CD4+ T cells 
therefore, T-bet regulates development of Th17 in T cell intrinsic manner. In T. cruzi 
mouse infection model, T-bet regulates Th17 development in T cell intrinsic manner. The 
authors showed the adoptive transfer of  naïve T-bet KO CD4+ T cells into RAG-2 KO 
enhance expression of IL-17 from CD4+ T cells more than WT transfer to RAG-2 KO 
mice [170]. 
 
The role of T-bet in different infectious and organ specific autoimmune disease 
models has been addressed in several studies [188-196] . In the S. mansoni mouse 
infection model, T-bet KO mice showed an increase in disease severity accompanied by 
upregulation in Th17 cytokines compared to WT infected mice [169]. T-bet KO mice 
infected with schistosome egg antigen in CFA (SEA/CFA) developed larger liver 
granulomas infiltrated with neutrophils compared to WT infected mice [169]. 
Furthermore, there was an increase in Th17 effector cytokines (IL-17, IL-21, and IL-22) 
as well as neutrophil chemokines CXCL1 and CXCL2 [169]. In another parasitic mouse 
infection model, T-bet KO mice develop a strong Th17 response in the spleens compared 
to WT mice following T. cruzi infection. Also there was an increase in the number of 
neutrophils in the blood [170]. T-bet does not regulate only granuloma formation and 
Th17 response in disease, but also it can regulate fibrosis. For example, in 
bleomycin-induced lung injury mouse model, T-bet KO mice were characterized by an 
increase in lung collagen content as a marker for fibrosis compared to WT mice [64]. 
 
Since T-bet KO mice exposed to SR were characterized by an increase in Th17 
cells as well as an increase in disease severity, the next experiment is to figure out if 
Th17 cells are required for granuloma formation. To address this question, previous 
studies in our lab used IL-6 KO mice. IL-6 is one of the cytokines required for Th17 
development [16]. When the lung cells from these mice were culture in vitro with 
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PMA/Ionomycin and intracellular cytokine staining was used to phenotype these cells, it 
was determined that the absence of IL-6 resulted in a significant decrease in Th17 
percentage and increase in Th1 percentage in the lungs of IL-6 KO exposed mice 
compared to WT exposed mice. However, there was no difference in granuloma 
formation between WT and IL-6 KO exposed mice as examined by H&E staining. These 
data indicated that Th17 were not required for granuloma formation and Th1 response 
was sufficient for granuloma formation indicating that both Th1 and Th17 may coexist 
during HP. Several experimental disease models showed the coexistence of both Th1 and 
Th17 cells during the disease progression. In EAE, both Th1 and Th17 are infiltrating the 
CNS [178] and antigen specific Th1 or Th17 generated in vitro adoptively transfer the 
disease into naïve mice [179]. In T. cruzi mouse infection model, normal Th1 response 
developed upon antigen challenging along with strong Th17 response [170]. In 
experimental autoimmune uveitis as a model for human uveitis, either Th1 or Th17 can 
cause the disease [177]. The cooperation between both types of T cells was demonstrated 
in EAE model where Th1cells collaborate with Th17 cells by facilitating the entry of 
Th17 into CNS [180]. In the same line of evidence, during HP either Th1 or Th17 may 
cause disease severity and the tipping balance point between both populations might 
regulate the disease severity. 
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CHAPTER 4.   EFFECT OF TLR2 AND 9 IN APCS ON TH17 CELL 
POLARIZATION AND EFFECTOR FUNCTION 
 
 
The results from chapters 2 and 3 demonstrated that the Th17 response was 
predominant over the Th1 response during HP and may contribute to disease severity. 
Consequently, we were looking for other factors that might control the Th17 response in 
our model. Activation of antigen specific T cells depends on interactions with innate 
immune cells which in turn are activated by the presence of a microbe. The innate 
immune cells recognize microbes using Toll like receptors (TLRs) expressed on the cell 
surface and in the cytoplasm. Previous results in our lab showed that the frequency of 
Th17 cells was significantly less in the lungs of TLR 2/9 double Knockout (DKO) mice 
compared to WT mice during HP. The aim of this chapter is to determine whether TLRs 
2 and 9 expressed by antigen presenting cells contributes to the Th1 or Th17 response 
during HP.  
 
 
INTRODUCTION 
Antigen Processing, Presentation, and Recognition Processes 
As introduced in chapter one, naïve T cell differentiation takes place in the lymph 
nodes where DCs are presenting specific antigen to naïve T cells. DCs provide naïve T 
cells with three signals. The culmination of the three signals ultimately leads to T cell 
differentiation into Th1, Th2, or Th17. The process of T cell differentiation requires the 
combination of sequential processes that take place at different anatomical sites. The first 
process occurs at the site of infection where immature DCs, that have a high phagocytic 
activity, phagocytose the microbial pathogen. Consequently, DCs undergo a maturation 
program allowing them to migrate to the regional lymph nodes and present the microbial 
antigen to naïve T cells. Immature DCs express a wide range of phagocytic receptors 
involving lectins and scavenger receptors with a very high phagocytic activity; however, 
once they get exposed to an inflammatory signal e.g. TLR ligand or inflammatory 
cytokine, they undergo a program of maturation. Mature DCs are mainly functional as 
antigen presenting cells. There are several events that occur during the DC maturation 
process. For example, downregulation of their phagocytic capacity, translocation of 
MHCII from the lysosomal compartment to plasma membrane increasing the expression 
of MHCII on the cell surface, upregulation in MHCI and costimulatory molecules 
expression as well [5]. All of these characteristics endow mature DCs with the capacity to 
become the most efficient APCs for priming naïve T cells at the lymph nodes while 
macrophages are inherently oriented towards activation of effector T cells already present 
at the site of inflammation. Also, the macrophages lysomal compartment is more adapted 
toward complete clearance of the microorganism [201]. 
  
Following phagocytosis, antigen presentation and antigen recognition processes 
take place. The recognition of antigens by T cells is a crucial process both in terms of 
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initiating the adaptive immune response at the lymph nodes as well as maintaining the 
effector phase of the immune response at the site of infection. Antigen recognition by 
T cells as mentioned earlier is preceded by two subsequent processes; antigen processing 
and presentation. Antigen processing begins with a form of internalization in which the 
immune cells engulf the cargo (microorganism or particulate) as one mechanism of host 
defense. Phagocytic innate immune cells such as macrophages and dendritic cells are 
capable of phagocytosis as a mode of internalization. They are also capable of performing 
other processes of internalization including macropinocytosis and clathrin and 
non clathrin-mediated endocytosis [201]. Phagocytosis, which was discovered by Elie 
Metchnikoff in 1882, is an internalization process initiated by binding of a 
microorganism or particle to phagocytic receptors on cell surface. This binding triggers a 
cascade of signaling events inducing cytoskeleton remodeling which allows membrane 
movement; consequently, engulfment of the cargo and phagosome formation occurs. The 
phagosome is the organelle that contains the cargo. It undergoes a series of events 
including fission and fusion with endosomes and lysosomes to ultimately generate 
phagolysosome, a process called phagosome maturation [202-204]. The lysosomes 
contain a harsh acidic environment due to vacuolar ATPase assembly which is pumping 
in protons from the cytoplasm. Also it contains proteolytic enzymes for protein 
degradation and peptide generation. The acidic pH denatures the proteins to be easily 
degradable by proteolytic enzymes [205]and these conditions favor the generation of 
antigenic peptides. In the endoplasmic reticulum (ER), the newly synthesized MHCII is 
associated with an invariant chain (Ii) that leads MHCII from the ER to the endocytic 
pathway. The invariant chain is cleaved by the proteases in the endosome leaving Class 
II-associated Ii derived peptide (CLIP) in the MHCII binding groove. Finally, CLIP is 
exchanged by the antigenic peptide with the help of  a MHCII like chaperone in the 
presence of acidic pH [201]. 
Effect of TLRs Signaling on Phagocytosis 
Toll-like receptors (TLRs) belong to a family of germline-encoded pattern 
recognition receptors (PRRs). They detect conserved microbial structures called 
pathogen-associated molecular patterns (PAMPs). TLRs are considered as type I 
transmembrane glycoprotein receptors made of three domains. The N-terminal 
ectodomain which is responsible for recognition of PAMPs; a transmembrane domain; 
and the C-terminal intracellular domain that shows homology with IL-1 receptor for that 
it is called Toll/IL-1 receptor domain (TIR). The TIR domain interacts with different 
adapter proteins such as MyD88 to activate downstream signaling. The stimulation of 
MyD88 leads to activation of NFkB signaling and the MAPK (mitogen-activated protein 
kinase) pathway which is important for expression of cytokines and chemokines such as 
IL-6, TNF? and IL-8. Humans and mice have 10 and 13 different form of TLRs 
respectively. TLRs 1-9 are conserved in both species with the absence of TLRs 11, 12, 
and 13 in humans and non-functional TLR10 in mice. TLRs are further classified into 2 
subgroups based on their localization. For instance, TLRs 1, 2, 4, 5, 6, and 11 are 
expressed on the cell surface, while TLR 3, 7, 8, and 9 are expressed in intracellular 
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compartments such as endosomes, lysosomes, and endoplasmic reticulum for recognition 
of nucleic acids [206]. 
Although TLRs have been known for their induction of cytokine expression, 
several studies examined the effect of TLR signaling on phagocytosis. Blander and 
Medzhitov demonstrated that TLRs regulate phagocytosis at different levels [207]. The 
authors showed a defect in internalization of E. coli, S. aureus, and heat-killed 
S. typhimurium by TLR2/ 4 DKO and MyD88KO bone marrow-derived macrophages 
compared to WT counterparts. Furthermore, there was incomplete colocaliztion of GFP 
labeled E. coli with a marker for late endosomes and lysosomes indicating a defect in 
phagosome maturation [207]. Finally, inhibition of p38 mitogen-activated protein kinase 
(MAPK) impaired the ability of macrophages to phagocytose E. coli. [207]. In 
conclusion, TLR signaling affects the phagocytosis process. 
 
It was also examined if TLRs signaling can affect antigen presentation as a 
subsequent process to phagosome maturation [208]. They found that a phagosome that 
carries a microbial cargo, i.e. pathogen binding to TLR, is able to mature to endosomal 
and lysosomal compartments and the microbial peptides will have access to MHCII for 
peptide-MHCII loading; hence their transportation to cell surface. On the other hand, 
phagocytosis of apoptotic cells generate peptides in phagolysosomal compartment; 
however, the peptides do not have access to MHCII and consequently the formation of 
peptide-MHCII complex is inhibited [208]. In summary, the type of the cargo packed 
with TLR in the phagosome can dictate the fate of the phagosome.  
 
Other studies have shown the effect of TLRs on phagocytosis in several bacterial 
infections. For instance, in pneumococcal infection, TLR9 and MyD88 deficient alveolar 
and bone marrow-derived macrophages develop defects in internalization as well as 
bacterial killing compared to WT counterparts [209] showing that TLR signaling is 
indispensible for defense against Streptococcus pneumoniae. Furthermore, macrophages 
from TLR2 KO and MyD88 KO mice were impaired in L. monocytogenes uptake [210] 
After intraperitoneal infection, TLR2KO and MyD88KO peritoneal macrophages have 
low numbers of L. monocytogenes compared to WT [210]. In conclusion, TLRs can 
affect the phagocytosis process in different bacterial infection models. 
 
 
Effect of TLRs Signaling on Costimulatory Molecules and Cytokine Expression 
 
As mentioned earlier, both ligation of costimulatory molecules and the 
appropriate cytokine milieu are required for differentiation of naïve T cells. Several 
studies showed the effect of TLRs not only on phagocytosis but also on the expression of 
cytokines and costimulatory molecules [211-213]. For instance, it was demonstrated that 
peptidoglycan-associated lipoprotein (PAL) of L. pneumophila is responsible for 
induction of proinflammatory cytokines IL-6 and TNF??from peritoneal macrophages 
through TLR2. Furthermore, the production of IL-6 and IL-12 was enhanced by 
costimulation with PAL and CpG ODN as a synthetic stimulus for TLR9. These data 
showed that TLRs2 and 9 induce proinflammatory cytokines from peritoneal 
66 
macrophages in a cooperative manner [211]. Additionally, PAL induced cell surface 
expression of MHCI and II molecules and costimulatory molecules CD40, 80, and 86. 
Also, costimulation with PAL and CpG ODN increased CD80, CD40, and MHCII 
expression but not CD86 and MHCI expression when compared to PAL stimulation alone 
[211]. In another study, Helicobacter pylori stimulated production of IL-6, IL-8, IL-10, 
and IL-12 production from immature human DCs in a dose-dependent manner. There was 
also an increase in mean fluorescence intensity (MFI) of CD80, CD83, and CD86 as well 
as MHCII [212]. Different species of lactobacillus induce different cytokines such as 
IL-6, IL-10, IL-12, and TNF??as well as upregulation of CD86 and MHCII [213]. In 
conclusion, signaling through different types of TLRs affects the expression of 
costimulatory molecules and cytokines. 
 
 
The Role of TLRs in Innate and Adaptive Immunity during HP 
 
Previous studies in our lab have shown the crucial role of MyD88 in neutrophil 
recruitment and chemokine expression during the innate phase of HP [127]. Our lab 
wanted to identify the TLRs upstream of MyD88 that interact with SR. Since SR is a 
gram-positive bacterium, in vitro studies demonstrated that TLR2 was the candidate PRR 
used by SR [127]. We used TLR2 KO mice to investigate whether SR interact with TLR2 
to effect neutrophil recruitment and chemokine expression. TLR2 KO mice had a 
decrease in neutrophil recruitment although it did not reach statistical significance 
compared to the WT mice exposed to SR. CXCL2 was significantly downregulated in 
TLR2 KO adherent splenic cells following in vitro SR stimulation when compared to WT 
counterparts [127]. These data demonstrated that while TLR2 contributes to neutrophil 
recruitment there is another TLR(s) that also plays a role. One other candidate is TLR9 
which is expressed intracellularly in endosomes to recognize CpG motifs in bacterial 
DNA. TLR2/9 DKO mice were generated by the lab to investigate if TLR9 cooperates 
with TLR2 to control neutrophil recruitment. Previous data in our lab showed that 
TLR2/9 DKO mice had a significant reduction in neutrophil recruitment as well as 
neutrophil chemokine expression following SR exposure for 6 hours as compared to WT 
counterparts. Also, there was a significant reduction in neutrophil chemokine (CXCL2) in 
TLR2/9DKO mice following three weeks of SR exposure. In conclusion, both TLRs 2 
and 9 affect neutrophil recruitment during HP through regulation of neutrophil 
chemokine (CXCL2). 
 
Previous data in our lab also demonstrated that following three weeks of SR 
exposure, the frequency of Th17 cells was higher in the lungs of WT mice compared to 
TLR2/9 DKO mice. A multitude of factors can control this phenomenon. First, the 
inability of DCs in the lymph nodes to polarize naïve T cells efficiently to effector 
Th17 cells due to a defect in costimulatory molecules and/or cytokine expression by DCs. 
Second, the efficiency of Th17 polarization in the lymph nodes might be equal in both 
WT and TLR2/9 DKO mice, but there is a defect in the process of effector Th17 cell 
migration from lymph nodes to the lungs of DKO mice. Finally, polarization and 
migration of Th17 cells might be equally efficient in both WT and TLR2/9 DKO mice; 
however, there could be a defect in antigen presentation capability of antigen presenting 
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cells (APCs) in the lungs of TLR2/9 DKO mice where they are unable to stimulate 
Th17 cells to produce IL-17 as an effector cytokine. In conclusion, one or a combination 
of these scenarios might occur. The aim of this chapter is to determine whether antigen 
processing or presentation by TLR2/9 deficient innate immune cells is responsible for the 
decrease in IL-17+ CD4 + T cells in the lungs. 
 
 
METHODS  
Animals 
Female C57BL/6J WT and MyD88KO mice were purchased from Jackson 
Laboratories (Bar Harbor, ME) and used in experiments between 6 – 10 weeks of age. 
TLR9 KO mice were originally obtained from Dr. A.K Yi, (Dept. of Pediatrics, 
University of Tennessee Health Science Center) and the colony was maintained at 
UTHSC. The TLR9 KO mice were crossed with TLR2 KO mice to generate 
TLR2/9DKO mice which were bred at the University of Tennessee Health Science 
Center and were used in at least 5th generation backcross. Sterile micro-isolator cages 
with sterile food and water ad libitum were used for animal housing. All the protocols 
were approved by the Institutional Animal Care and Use Committee (IACUC), the 
University of Tennessee Health Science Center. All animals were maintained by the 
Division of Comparative Medicine at University of Tennessee Health Science Center 
according to the guidelines of the animal welfare act. 
 
 
Antigen Presentation Assay 
 
Isolation of CD4+ T Cells 
WT and TLR2/9 DKO mice were exposed to 150ug lyophilized SR for three 
weeks. Mice were sacrificed 16-18 hrs following last exposure. BAL was performed 
using 10ml of sterile PBS-EDTA (0.1mM) to remove most of the alveolar macrophages 
and neutrophils from the air space. Lungs were perfused using 10ml of sterile PBS and 
then harvested for collagenase/DNase digestion. Single cell suspension was prepared 
using stomacher. Lung total T cells were enriched by an adherence step where cell 
suspension was cultured in 100mm petri-dishes. Following 2 hours of incubation at 37°C, 
non-adherent cells were collected and the plate was washed once with PBS. CD4+ T cells 
were enriched by negative selection method (BD IMag). The purity was usually between 
70-80% CD4+ T cells. 
Isolation of Adherent Cells 
One day before the experiment, spleen cells were harvested from WT and TLR2/9 
DKO mice and single cell suspension were prepared using a Stomacher. The cell 
suspension from each genotype was cultured in a 100mm petri-dish and incubated at 
37°C for 2 hours then adherent cells were harvested. In a 6-well plate, 5x106 adherent 
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spleen cells were plated and stimulated with 8x107 CFU of heat-killed SR (HKSR) for 24 
hours. Another group of adherent spleen cells were incubated for 24 hours without 
HKSR. The reason behind the 24 hours incubation was to give time for the adherent 
spleen cells to phagocytose, process, and present SR antigen. Next day (the day of the 
experiment), adherent spleen cells were harvested by incubating them with PBS for 15 
minutes at 4°C and then washed with media for 3 times to get rid of free unphagocytosed 
SR. 
 
Co-Culturing CD4+ T Cells with Unstimulated or Stimulated Adherent Spleen Cells 
In a 96-well plate, CD4+ T cells and adherent spleen cells were cocultured at 1:1 
ratio. Fig. 4-1 summarizes the antigen presentation assay. 
Generation of Bone Marrow Derived Macrophages and Dendritic  
Preparation of Bone Marrow Derived Macrophages (BMDMs) Cell Culture Medium  
L-929 culture conditioned medium (LCCM) was used as the source of M-CSF 
(Macrophage Colony Stimulating Factor) to generate macrophages from bone marrow 
in vitro. The L-929 murine fibroblast cell line was obtained from Dr. Ted Strom 
(VAMC). The cells were maintained in DMEM containing 10% heat inactivated FCS, 
Glutamine (2mM), and penicillin/streptomycin (100U/ml and 100?g/ml). After 4-5 days, 
the culture supernatant was collected and stored at -20°C, and the cells were split into 
flasks with a larger surface area. 4-5 days later the supernatant was collected and pooled 
with the previous collection. After collecting 1-2 liters of supernatant, the whole 
preparation was thawed once then aliquoted into 50ml tubes and stored at -80°C. The 
complete conditioned cell culture medium used for generation of bone marrow-derived 
 
 
 
 
Figure 4-1. Steps for setting up antigen presentation assay. 
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macrophages contained DMEM (Cellgro, Mediatech Inc., Manassas, VA) supplemented 
with 15% heat inactivated FCS, Glutamine (2mM), Penicillin/Streptomycin (100U/ml 
and 100?g/ml), 50?g/ml gentamicin (GIBCO cell culture Invitrogen; Carlsbad, CA) and 
30% L-929-cell-conditioned medium (LCCM).  
 
Generation of BMDMs 
 
Bone marrow cells were harvested from the tibias and femurs of C57BL/6J, 
TLR2/9DKO, and MyD88 KO mice by flushing with sterile PBS. The RBCs were lysed 
and the bone marrow cells were washed and suspended in 15ml of complete conditioned 
medium. The cell suspension was plated in 100mm non-tissue culture petri-dishes and 
incubated at 37°C. The next day, non-adherent cells were collected, counted, and plated 
at 5x106 cells/dish in a 100mm petri-dish with 15ml of complete conditioned medium. On 
day 3, half of the media was removed and replenished with conditioned medium 
containing 60% LCCM. On day 6 or 7, adherent cells were harvested using sterile 1mM 
PBS/EDTA for 15 minutes at 37oC, followed by a wash with sterile PBS. Cells were 
analyzed by flow cytometry using antibodies to CD11b and F4/80. Macrophages were 
identified as CD11b+/F4/80+, and purity was routinely between 80-85%.  
 
Preparation of Bone Marrow Derived Dendritic Cell (BMDCs) Culture Medium  
 
The B16 F10 melanoma cell line was obtained from Dr. Cohen (University of 
Kentucky). The cells were transfected with mrGMCSF to be used as a source of 
GM-CSF. They were maintained in DMEM containing 10% heat-inactivated FCS, 
glutamine (2mM), penicillin/streptomycin (100U/ml and 100?g/ml), and 2mg/ml G-418 
to maintain the transfectants. Once the cells were confluent, they were split into flasks 
with a larger surface area till reach confluency. The cells were split again into larger 
flasks and grown for 1 week without G418; then they were frozen and used again without 
G418 for a maximum of 2 weeks of passage. During this period of time, culture 
supernatant was collected and stored at -80°C. 
 
Generation of BMDCs  
 
Bone marrow cells were harvested from the tibias and femurs of C57BL/6J, and 
TLR2/9 DKO mice by flushing with sterile PBS. The RBCs were lysed and the bone 
marrow cells were washed in media and resuspended in 15ml of complete conditioned 
medium. The cell suspension was plated in a 100mm petri- dish. On day 3, 75% of the 
media was removed to get rid of neutrophils and replenished with complete conditioned 
medium. On day 6-7, non-adherent cells were harvested and dendritic cells were enriched 
using a mouse Dendritic Cell Enrichment Kit (BD Biosciences; San Jose, CA) following 
the manufacturer’s instructions. The cells were analyzed by flow cytometry using 
antibodies to CD11b, CD11c, CD80, and CD86. Immature BMDCs were identified as 
CD11b+/, CD11c+/CD80lo/CD86lo. 
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Phagocytosis Assays 
Preparation of Carboxyfluorescein Succinimidyl Ester (CFSE)-Labeled Lyophilized SR 
for in vitro Phagocytosis Assays  
 
A 5mg/ml SR aliquot was washed with PBS twice by centrifugation at 10,000xg 
for 5 minutes. The pellet was resuspended in 500?l sterile PBS and CFSE (Invitrogen, 
Carlsbad, CA) was added at a final concentration of 1?M and incubated at 37oC in the 
dark. The labeled bacteria were washed 3 times with PBS by centrifugation at 10,000xg 
for 5 minutes. The labeling efficiency was measured by flow cytometry and typically 
between 80-85% of the bacteria were labeled.   
 
Preparation of TAMRA Labeled Live SR for in vivo Phagocytosis Assays  
 
An aliquot of 40x108 CFU/ml live SR was washed with PBS twice by 
centrifugation at 10,000xg for 5 minutes. The pellet was resuspended in 400?l sterile 
PBS then incubated with TAMRA dye (final conc. 12.5?g/ml) on ice for 10min in the 
dark. The pellet was washed with PBS 3 times and then resuspended in 1ml PBS. 
Labeling efficiency was checked by microscopy, and it was approximately 90%. 
 
In vitro Phagocytosis 
 
In vitro phagocytosis using flow cytometry: BMDCs or BMDMs were used for 
in vitro phagocytosis assays. Ninety ?g/250?l CFSE labeled SR was opsonized with 8% 
normal mouse serum at 37°C. Following 1 hour incubation, the opsonized bacteria were 
washed twice with sterile PBS then centrifuged at 10,000xg for 3 minutes. In a 5ml 
FACS tube (BD Falcon), 5x105 BMDCs were incubated with the opsonized labeled 
bacteria on ice for 30 minutes to allow the binding of bacteria to the cell surface. Tubes 
were then incubated at 37oC for 20, 60, 120, 180, or 240 minutes. As a negative control, 
10?g/ml Cytochalasin D (Sigma-Aldrich, St. Louis, MO) was added to inhibit actin 
depolymerization and hence phagocytosis. Cells were also incubated with unlabeled SR 
at 37°C to gate out fluorescence background and with labeled opsonized SR on ice as 
another control. Cells were washed twice with cold PBS to stop phagocytosis then 1ml of 
0.4% Trypan blue was added to quench extracellular fluorescence then cells were washed 
once with PBS. Finally, the cells were fixed with 100?l 4% paraformaldehyde (BD 
Cytofix™ ) for 15 minute on ice. By gating on live cells using Forward and side scatter, 
the percent of BMDCs that phagocytosed labeled SR was measured by flow cytometry. 
 
In vitro phagocytosis using confocal microscopy: In 24 well plate containing 
cover slips, WT or TLR2/9 DKO BMDMs (7.5x105 cells/well) were cultured in RPMI 
5% FCS for 18 hours to allow adherence. Next day, the cells were incubated with live 
opsonized TAMRA labeled SR for 1 hour and 2 hours at MOI 50. For Cytochalasin D 
control, certain wells were treated with Cytochalasin D (10?M) for 30 minutes before 
incubation with SR.  Following incubation times, media were removed and phagocytosis 
was stopped by cold PBS then wells were washed to remove free SR. The cover slip was 
removed carefully and placed on a glass slide with mounting media (50% glycerol in 
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PBS). Each slide contains 3 cover slips representing triplicates from 3 wells. Using LSM 
710 confocal microscope, BMDM that contained one or more red dot was counted as one. 
Cells that contain any dispersed red speckles were not counted as positive cell. Total cells 
in the field were counted then positive BMDMs that internalize SR were counted; finally, 
the percentage of BMDMs that phagocytose SR was calculated. 
In vivo Phagocytosis  
In vivo phagocytosis using flow cytometry: WT and TLR2/9 DKO mice were 
exposed to 200?g of CFSE labeled lyophilized SR. One hour post-exposure the mice 
were sacrificed and BALF was collected using 10ml of sterile 1mM EDTA-PBS. The 
cells were recovered from the BALF by centrifugation. The cell suspension was 
centrifuged for 5min at 1500 rpm then extracellular fluorescence was quenched using 1ml 
of 0.4% Trypan blue then incubated for 1 minute at room temp. The cell suspension was 
washed with PBS then centrifuged for 5 min at 1500rpm. Finally, the cells were fixed 
using 200?l 4% paraformaldehyde. The percent of alveolar macrophages phagocytosing 
labeled SR was measured by flow cytometry. Mice exposed to unlabeled SR were used as 
a negative control to gate out fluorescence background. 
 
In vivo phagocytosis using confocal microscopy: WT and TLR2/9 DKO mice 
were exposed to 2x108 CFU/50ul TAMRA labeled live SR. One hour post-exposure the 
mice were sacrificed and BALF was collected using 10ml of sterile 1mM EDTA-PBS. 
The cells were recovered from the BALF by centrifugation and then fixed with 200?l 4% 
paraformaldehyde. The cell suspension was cytospined using cytospin columns for 5min. 
at 1500 rpm. The percent of alveolar macrophages phagocytosing labeled SR was 
counted using LSM 710 Ziess confocal microscope by merging fluorescent field with 
bright field. 
 
 
In vitro Stimulation of BMDMs Using SR 
 
5x105 BMDMs/well were stimulated with media or 10?g SR. Following 24 hours 
of stimulation, culture supernatant was harvested for detection of cytokines using 
Multiplex Sandwich Assay and ELISA. 
 
 
Multiplex Sandwich Immunoassay  
 
Cytokines in the culture supernatant harvested from stimulated BMDMs were 
detected using MILLIPLEX MAP Immunoassay kit (Millipore, Billerica, MA) per 
manufacturer’s instructions. The concentration of the cytokine was determined by setting 
up standard curves ranging from 3.2 to 10,000 pg/ml. Sample concentrations were 
extrapolated from four parameter log standard curve in Milliplex software analyst. The 
whole process of cytokine detection using a luminex instrument was done by Dr. Mark 
Miller. 
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ELISA 
Measurement of IFN? 
 
Mouse IFN? capture antibody (BD Opt EIA, San Diego, CA) was diluted 1:250 in 
coating buffer (0.1M Sodium Carbonate, pH 9.5). In a 96 well plate, 100?l of the diluted 
capture antibody/well was added and incubated at 4oC. Following an overnight 
incubation, the plate was washed 5 times with wash buffer (PBS + 0.05% Tween-20); 
then the plate was blocked with 200?l assay diluent (PBS + 10% FBS)/well and 
incubated at room temperature. After 1 hour incubation, the plate was washed again. 
From the stock standard, 2000pg/ml was prepared as the highest point in the standard 
curve; then a 2-fold dilution was prepared from the first concentration, ending with 
15.6pg/ml as the lowest concentration. One hundred ?l/well from each dilution was 
plated in duplicates and 100?l/well of the sample was plated as well. The plate was 
incubated for 2 hours at room temperature with slow rocking, then washed 5 times. 
Working detector was prepared by diluting both Biotinylated anti-mouse IFN? (BD Opt 
EIA, San Diego, CA) (1:250) and streptavidin-horseradish peroxidase conjugate (BD Opt 
EIA, San Diego, CA) (1:250) in assay diluent. One hundred ?l of the working 
detector/well was added, the plate was sealed, covered, and incubated at room 
temperature for 30 minutes. The plate was washed 10 times, soaking the wells with 
washing buffer for 1 minute each time. The plate was developed by adding 100?l/well 
TMB substrate (BD Biosciences, San Diego, CA), then incubated for 30 minutes at room 
temperature in the dark. To stop the color reaction, 50?l/well of 2N sulphuric acid was 
added. The plate was read on a Spectra Max 340 plate reader (Molecular Devices, 
Sunnyvale, CA) at 450 and 570nm to subtract background absorbance. Data was 
analyzed by SoftMax® Pro software Version 5 (Molecular Devices, Sunnyvale, CA) 
using a 4-parameter standard curve. 
Measurement of IL-23p19 
Using assay diluent, highest standard concentration (1000pg/ml) was prepared 
from the standard stock; then a 2-fold dilution was prepared from the first concentration, 
ending with 7.8pg/ml as the lowest concentration. One hundred ?l/well from each 
dilution was plated in duplicate, and 100?l/well of the sample was plated as well into a 
96-well plate precoated with anti-mouse IL-23p19. Following 2 hours of incubation at 
room temperature, the plate was washed with assay diluent 5 times. Biotinylated anti-
mouse IL-12/23p40 (eBiosciences, San Diego, CA) was diluted 1:250 in assay diluent. 
100?l/well was plated and incubated at room temperature for 1 hour, then washed for 5 
times. 100ul of 1:250 diluted streptavidin-horseradish peroxidase conjugate 
(eBiosciences, San Diego, CA) was added and incubated in the dark for 30 minutes. After 
washing for 7 times with assay diluent, 100?l/well TMB substrate (eBiosciences, 
San Diego, CA) was added; then the plate was incubated for 15 minutes at room 
temperature in the dark. To stop the color reaction, 50?l/well of 2N Sulphuric acid was 
added. The plate was read on a Spectra Max 340 plate reader (Molecular Devices, 
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Sunnyvale, CA) at 450 and 570nm to subtract background absorbance. Data was 
analyzed by SoftMax pro software Version 5 using a 4-parameter standard curve. 
Statistical Analysis 
Values were expressed as mean ±S.D. For comparison of means between two 
populations of unpaired data, unpaired student’s t-test was used. For comparison between 
more than two groups, One-way ANOVA followed by Tukey’s post ANOVA test was 
used. GraphPad Prism 5 was used to perform all tests. Differences were considered 
significant at P <0.05. 
 
 
RESULTS 
 
 
TLRs 2 and 9 Did Not Affect Phagocytosis Ability of BMDCs 
 
One explanation for the decrease in Th17 cells in the lung is deficient 
phagocytosis of SR by TLR2/9 deficient APCs. To test this hypothesis, we generated 
BMDCs in vitro from WT and TLR2/9 DKO mice then incubated them with CFSE 
labeled SR at different time points and the internalization of CFSE labeled SR was 
measured by flow cytometry. The results revealed that there was no significant difference 
in the phagocytosis ability of either WT or TLR2/9 DKO at any time points; both WT 
and DKO were able to internalize labeled SR efficiently (Fig. 4-2). We used cytochalasin 
D as a control since it inhibits phagocytosis and we did find an inhibition of phagocytosis 
using cytochalasin D. We also used serum from C57BL/6J mice exposed to SR for 2 
weeks to develop antibodies against SR and use the serum for more efficient opsonization 
which will result in more efficient phagocytosis; however, we didn’t find a significant 
difference in phagocytosis using immunized or non-immunized serum. In conclusion, 
these results demonstrated that TLR2 and 9 did not affect the phagocytosis ability of 
BMDCs.  
 
 
TLRs 2 and 9 Did Not Affect Phagocytosis Ability of BMDMs 
 
We next analyzed events that occur downstream from the polarization of naïve T 
cells. Once effector T cells exit lymph nodes after their differentiation, they migrate to 
target tissue to perform their effector function (in our model the target tissue is the lung). 
Effector T cells require antigen presentation in the target tissue and the candidate cells in 
our model were interstitial macrophages.  
 
We hypothesized that interstitial macrophages in TLR2/9 DKO mice were not 
efficient in phagocytosis and hence deficient in their antigen presentation ability to 
stimulate effector Th17 cells in the lungs. To test this hypothesis, we tried to isolate 
interstitial macrophages from WT and TLR2/9 DKO mice but we faced several 
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Figure 4-2. Detection of internalized CFSE labeled SR in BMDCs using flow 
cytometry. 
 
One hundred thousand BMDCs were incubated with CFSE labeled SR (360?g/ml) at 
different time points. The percentage of BMDCs phagocytosing labeled SR was 
determined using flow cytometry. Each column represents n=3 except 20min time point 
was n=2. Results were expressed as means ± SD. Unpaired student’s t-test was used to 
compare between WT and TLR2/9 DKO phagocytosis ability within each time point. 
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limitations in the isolation technique such as the requirement to pool large number of 
mice and low purity. We decided to generate macrophages from bone marrow in vitro 
which gave us high yield and purity; therefore, we used BMDMs in phagocytosis assays.  
 
In vitro Phagocytosis Using Flow Cytometry  
 
We designed an in vitro phagocytosis assay using opsonized CFSE labeled SR to 
incubate with WT or TLR2/9 DKO BMDMs at different time points. The efficiency of 
SR internalization in both WT and TLR2/9 DKO BMDMs was measured by flow 
cytometry and then confirmed by confocal microscopy. We started with in vitro 
phagocytosis using flow cytometry to determine the best time point to be used next in the 
confocal microscopy. As shown in Fig. 4-3, there was not a significant difference at any 
time point 
 
In vitro Phagocytosis Using Confocal Microscopy  
 
The phagocytosis results using flow cytometry revealed that both TLR2 and 9 did 
not affect SR uptake ability by macrophages; however, these results need to be confirmed 
using a different technique. We used confocal microscopy to test if our flow cytometry 
results will be confirmed or not. WT or TLR2/9 DKO BMDMs were incubated with 
opsonized TAMRA labeled live SR at MOI 50 for one and two hours. Cytochalasin D 
was used as a control to inhibit phagocytosis. The internalization of SR was visualized by 
confocal microscopy after merging bright with fluorescent field. The phagocytosed 
labeled SR was visualized as red dot inside the cell. As shown in Fig. 4-4, there was no 
significant difference in phagocytosis ability of WT and TLR2/9 DKO. 
 
 
TLRs 2 and 9 Did Not Affect Phagocytosis Ability of AMs 
 
The in vitro phagocytosis results from both confocal and flow cytometry 
confirmed each other. To confirm the in vitro phagocytosis experiments, we performed in
vivo phagocytosis using AMs. Mice were exposed intranasally to labeled SR. One hour 
later, BAL was performed to collect BAL cells. The phagocytosis ability of WT and 
TLR2/9 DKO was determined by flow cytometry and confocal microscopy.  
In vivo Phagocytosis Using Flow Cytometry 
 
In vivo phagocytosis using AMs was done to confirm in vitro phagocytosis 
results. WT or TLR2/9 DKO mice were exposed to CFSE labeled SR. One hour later 
BAL was performed to collect BAL cells. The uptake of SR by AMs was measured by 
flow cytometry. As shown in Fig. 4-5, both WT and TLR2/9 DKO AMs were able to 
phagocytose CFSE labeled SR. 
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Figure 4-3. Detection of internalized CFSE labeled SR in BMDMs using flow 
cytometry. 
 
In a 96 well plate, 5x105 BMDMs were incubated with CFSE labeled SR (360?g/ml) at 
different time points. The percentage of BMDMs phagocytosing labeled SR was 
determined using flow cytometry. Each column represents n=2. Results were expressed 
as means ± SD. Unpaired student’s t-test was used to compare between WT and TLR2/9 
DKO phagocytosis ability within each time point. 
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Figure 4-4. Detection of internalized TAMRA labeled SR in BMDMs using 
confocal microscopy. 
 
Panels (A-P) represent confocal images by merging bright field with fluorescence field. 
Panels A and C are representative fields for WT and TLR2/9 DKO BMDMs 
phagocytosing TAMRA labeled SR (MOI 50 1 hour) respectively. Panels B and D are 
cropped image of the same fields. Panels E-H are same conditions as above except 
cytochalasin D was added. Panels I and K are representative fields for WT and TLR2/9 
DKO BMDMs phagocytosing TAMRA labeled SR (MOI 50 2 hours) respectively. 
Panels J and L are cropped image of the same fields. Panels M-P represents the same 
conditions except cytochalasin D was added. Data are representative of 12-15 
fields/sample for each condition. (Q) Quantification of phgaocytosis. Each column 
represents observation from 9 fields (3 fields/well). Total cells/field was counted then 
cells phagocytosing SR were counted to calculate percentage. Results were represented as 
means ± SD. Using unpaired student’s test, means between groups incubated with SR and 
group treated with Cytochalain D were compared. (***P ?0.0001 significant difference 
from cytochalasin D control.) 
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Figure 4-4.  (Continued).  
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Figure 4-4.  (Continued).  
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Figure 4-4.  (Continued).  
  
Q 
82 
Figure 4-5. Detection of internalized CFSE labeled SR in AMs using flow 
cytometry. 
WT or TLR2/9 DKO mice were exposed to 200?g of CFSE labeled SR. One hour later 
mice were sacrificed and BAL was performed to collect BAL cells. Extracellular 
fluorescence was quenched by Trypan Blue, and then washed with PBS. The cells were 
fixed with 4% paraformaldhyde, and finally the data was acquired on the flow cytometer. 
Each column represents n=8-9 combined from 5 independent experiments. Results were 
expressed as means ± SD. Unpaired student’s t-test was used to compare mean between 
WT and TLR2/9 DKO phagocytosis percentage. 
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In vivo Phagocytosis Using Confocal Microscopy 
To confirm the phagocytosis results from the flow cytometry method, we used 
confocal microscopy to examine if flow cytometry results match the confocal results. 
Both WT and TLR2/9 DKO were exposed to 2x108 CFU/50?l TAMRA labeled live SR. 
One hour later, BAL was performed to collect BAL cells. The BAL cells underwent 
cytospin on a glass slide. AMs phagocytosing labeled SR were visualized using confocal 
microscopy. As shown in the Fig. 4-6, there was no significant difference in the 
phagocytosis ability of both WT and TLR2/9 DKO AMs.  
 
 
TLRs 2 and 9 Did Not Affect the Antigen Presentation Ability of Splenic APCs 
 
Following T cell differentiation in the lymph nodes, effector T cells migrate to 
their target tissues, the site of inflammation; however, they still require antigen 
presentation by APCs to maintain their effector function there in. The candidate APCs in 
the lung parenchyma are lung interstitial macrophages. Since we observed a decrease in 
the frequency of Th17 cells in the lungs of TLR2/9 DKO mice compared to WT 
counterparts, we sought to examine the efficiency of WT and TLR2/9 DKO APCs in 
stimulating effector Th17 cells to produce IL-17 as effector cytokine.  
 
Phagocytosis is a process that precedes antigen presentation. We already 
demonstrated in the previous sections that TLRs 2 and 9 do not affect SR uptake by 
macrophages and dendritic cells. Consequently, we examined antigen presentation 
efficiency of macrophages using antigen presentation assay. 
 
In this assay, we tested the ability of both WT and TLR2/9 DKO APCs to present 
SR antigen to WT or TLR2/9 DKO effector Th17 cells isolated from lungs; and also if 
this stimulation of Th17 cells would produce IL-17. The measurement of Th17 effector 
function e.g. production of IL-17 is a reflection of the antigen presentation efficiency of 
APCs. The assay was set up as described in the methods section.  
 
The results demonstrated that both WT and TLR2/9 DKO CD4+ T cells were able 
to produce IL-17 regardless of the phenotype of APCs (WT or TLR2/9 DKO), indicating 
that TLR2/9 DKO APCs were equally efficient to present SR antigen to WT or 
TLR2/9 DKO CD4+ T cells. In conclusion, these results demonstrated that both WT and 
TLR2/9 DKO APCs were equally efficient in SR presentation to WT or TLR2/9 DKO 
CD4+ T cells (Fig. 4-7A). 
We also used SR lysate as a source of SR soluble antigen to examine if TLRs 2 
and 9 affect other internalization pathways than phagocytosis. We cocultured WT or 
TLR2/9 DKO CD4+ T cells with WT or TLR2/9 DKO APCs in the presence or absence 
of SR lysate. We found that both were able to present SR antigen and hence stimulate 
Th17 cells to produce IL-17 as effector cytokine (Fig. 4-7B). 
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Figure 4-6. Detection of internalized TAMRA labeled SR in AMs using confocal 
microscopy. 
WT or TLR2/9 DKO mice (n=3) were exposed to 2x108CFU/50?l TAMRA labeled live 
SR. One hour later mice were sacrificed and BAL was performed to collect BAL cells. 
The cells underwent cytospin on a glass slide. Panels (A-D) represent confocal images by 
merging bright with fluorescent fields. A and B are WT images while C and D TLR2/9 
DKO images. (E) Quantification for 24 fields from 3 mice. Results were expressed as 
means ± SD. Unpaired student’s t-test was used to compare between WT and TLR2/9 
DKO phagocytosis ability. 
 
 
  
85 
  
WT 40X 
TLR2/9 DKO 40X 
Cropped image 
Cropped image 
A B
C D
 
 
E 
86 
Figure 4-7. TLRs 2 and 9 did not affect antigen presentation ability of splenic 
APCs. 
 
WT and TLR2/9 DKO mice were exposed to SR (150ug) for 3 wks then CD4+ T cells 
were isolated with a negative selection kit (BD IMag) from lungs. (A) WT or TLR2/9 
DKO CD4+ T cells were incubated with HKSR stimulated WT or TLR2/9 DKO APCs 
for 18 hours. As negative control, unstimulated WT or TLR2/9 DKO APCs were 
incubated with WT or TLR2/9DKO CD4+ T cells. Following cell surface staining using 
anti-CD4 and anti-TCR? antibodies, intracellular cytokine staining for IL-17 and TNF?
was performed. Each bar represent n=4-6. Results were expressed as means ± SD 
***P?0.0001 and *P<0.02 which is significant difference from the unstimulated control 
using unpaired student’s test. (B) WT or TLR2/9 DKO CD4+ T cells were incubated with 
WT or TLR2/9 DKO APCs in the presence or absence of SR lysate for 8 hours. 
Following cell surface staining using anti-CD4 and anti-TCR? antibodies, intracellular 
cytokine staining for IL-17 and TNF? was performed. Each bar represents n=2-3. Results 
were expressed as means ± SD *P?0.05 and **P<0.01 which is a significant difference 
from media control using unpaired student’s test.  
(A) 
(B) 
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Effect of TLRs 2 and 9 on Cytokine Expression from BMDMs 
We hypothesized that cytokines produced by interstitial macrophages play a role 
in regulation of the inflammatory environment in the lungs and affect effector function of 
the T cells. In order to test this hypothesis, we stimulated BMDMs from WT, 
TLR2/9 DKO, and MyD88 KO in vitro with lyophilized SR for 24 hours then we 
collected the culture supernatant and measured IL-6, IL-10, IL-12p70, ?and TNF? using 
Multiplex sandwich immunoassay. We also measured IL-23 and IFN? using ELISA. We 
found a significant down regulation in the expression of the proinflammatory cytokines 
IL-6 and TNF? as well as the anti-inflammatory cytokine IL-10 from TLR2/9 DKO and 
MyD88 KO BMDMs compared to WT stimulated BMDMs. We did not find a significant 
difference between WT and TLR2/9 DKO when we measured IL-12p70 however; there 
was a significant down regulation in MyD88 KO BMDMs. We didn’t detect IL-23 and 
IFN? using ELISA. In conclusion, TLR2 and 9 and MyD88 down regulate IL-6, IL-10, 
IL12p70, and TNF? expression (Fig. 4-8). 
 
 
DISCUSSION 
 
 
TLRs 2 and 9 Did Not Affect the Phagocytosis Ability of DMDMs and BMDCs 
 
The process of naïve T cell differentiation to effector CD4+ T cell is crucial for 
initiation of adaptive T cell immunity. It requires a combination of sequential processes 
take place at different anatomical sites. The first process occurs at the site of infection 
where immature DCs, that have a high phagocytic activity, phagocytose the microbial 
pathogen. Consequently, DCs undergo a maturation program allowing them to migrate to 
the regional lymph nodes and present the microbial antigen to naïve T cells. Therefore, 
phagocytosis is an indispensable process for antigen presentation.  
 
Previous results from our lab have shown that following three weeks of SR 
exposure, the frequency of Th17 cells in the lungs of TLR2/9 DKO mice was 
significantly less compared to WT counterparts. Several possibilities underlie this 
observation. One possibility could be deficiency in the capability of TLR2/9 DKO 
immature DCs in the lungs to phagocytose the bacteria; hence, there will be a defect in 
antigen presentation that will result in impairment in polarization of naïve T cells to 
effector Th17. To test this hypothesis, we first measured the phagocytosis ability of WT 
and TLR2/9 DKO BMDCs using CFSE labeled SR. The results revealed that there was 
not a significant difference in the phagocytosis capability for either WT or TLR2/9 DKO 
BMDCs at different time points. This data suggested that both WT and TLR2/9 DKO 
BMDCs were equally efficient in phagocytosis. 
 
Next, we planned to measure costimulatory molecules, MHCII, and cytokine 
expression using BMDCs. However, we faced several limitations regarding the purity of 
BMDCs. We only obtained 40-50% CD11c+ as a marker for DCs. Consequently, we  
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Figure 4-8. Expression of IL-6, TNF?, IL-10, and IL-12p70 from WT, TLRs 2/9 
DKO and MyD88 KO BMDMs following in vitro SR stimulation. 
 
In a 96 well plate, 5x105 cells/well were plated and stimulated with media or 10?g SR. 
Twenty-four hours later culture supernatant was collected to measure the cytokines using 
Multilex sandwich assay. Each bar represents n=4. Results were represented as means 
±SD. One way ANOVA followed by Tukey’s post ANOVA test was used to compare the 
means of three groups (***P<0.0001). N.D (not detected). 
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shifted our efforts to optimize a protocol for isolation of mouse splenic DCs. We obtained 
~65% CD11c+ cells but the yield was very low (2-3x105 cells from 2 spleens). As an 
alternative way to circumvent these obstacles, we might use mediastinal lymph nodes 
(draining lymph node for the lungs) from three weeks SR exposed mice to check 
expression of costimulatory molecules and cytokines using intracellular cytokine staining 
by gating on dendritic cells. In order to compare results to unexposed mice, we need to 
pool a large number of unexposed mice. 
 
As discussed earlier, the defect in factors required for polarization of naïve T cells 
by DCs was only one possibility that lies behind the decrease of Th17 frequency in the 
lungs of TLR2/9DKO mice. The other possible rational could be a defect in the antigen 
presentation capability of lung interstitial macrophages to present SR antigen to effector 
T cells. Following polarization of naïve T cells in the lymph nodes, effector T cells 
migrate to the site of infection to start their effector function however; they still require 
antigen presentation and costimulatory molecules provided by interstital macrophages at 
the site of infection. To test if there is a defect in TLR2/9 DKO APCs’ antigen 
presentation ability, first we examined their phagocytosis ability as a process that 
precedes antigen presentation. We started our initial studies by setting up in vitro 
phagocytosis assays using BMDMs. We tried isolating interstitial macrophages from WT 
and TLR2/9 DKO but one of the main obstacles was pooling large number of mice. For 
that reason, we used BMDMs in the in vitro phagocytosis assays. We found that both WT 
and TLR2/9 DKO BMDMs were equally efficient in SR uptake using both flow 
cytometry and confocal microscopy techniques. To confirm the in vitro data, we setup in
vivo phagocytosis assays using flow cytometry and confocal microscopy techniques. Our 
data demonstrated that WT and TLR2/9 DKO AMs were able to phagocytose SR 
efficiently; however, the results of in vivo phagocytosis obtained from flow cytometry 
were higher than results obtained from confocal microscopy. There are several reasons 
that could explain this difference. One explanation could be a matter of technique 
sensitivity, since in the confocal microscopy when we analyzed the data; we set up 
certain criteria when counting the cells phagocytosing SR. Only cells with red dots were 
counted and any red dispersed speckles were not counted which could be detected by 
flow cytometry as a positive signal. 
 
One of the drawbacks of using confocal images by merging fluorescence with the 
bright field is proving whether bacterium is intracellular or attached to the cell. We can 
tell that labeled SR is inside by looking for the borders of the cell which includes the 
cytoplasm and the nucleus; however, SR could adhere to the cell surface and will not be 
washed away. Finally, we do not know in which compartment the bacterium resides. 
There are a couple ways to circumvent these pitfalls. First, we could label the bacteria 
with Oregon green followed by biotin labeling then incubate the biotinylated labeled 
bacteria with the cells to allow phagocytosis (1 or 2 hours). Following incubation, 
rhodamine-sterptavidin would be added for 30 minutes. If the biotinylated labeled 
bacterium is phagocytosed, it will be visualized in the FITC (green) channel only, and if 
the bacterium is extracellular or attached to cell surface, it will be visualized in both 
channels FITC and rhodamine and appear as yellow on merging between the two 
channels. In other words, extracellular or adhered bacterium will be yellow while 
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intracellular bacterium will be green on merging between 2 channels. Using lysomal 
markers (LAMP1 and LAMP2) could be another way to confirm the internalization of the 
bacterium. Both labeled bacterium and cells labeled with lysosomal markers are detected 
in different channels. Only internalized bacterium will be visualized by merging between 
the two channels.  
TLRs 2 and 9 Did Not Affect the Antigen Presentation Ability of Splenic APCs 
Following phagocytosis, the antigen is processed to be presented by MHC. We 
already tested the phagocytosis ability of both WT and TLR2/9 DKO BMDMs and 
BMDCs. As a subsequent process, we will investigate antigen presentation process to 
examine if there is a difference in the antigen presentation ability of both WT and 
TLR2/9 DKO APCs. If we observe a difference, we will start investigating the steps that 
precedes antigen presentation i.e. antigen processing that might lead to a defect in antigen 
presentation. A defect in antigen presentation might reflect why we see a decrease in the 
frequency of Th17 cells in lungs of TLR2/9 DKO mice.  
We hypothesized that TLR2/9 DKO APCs were not able to phagocytose and 
hence present SR antigen to effector Th17 cells in the lungs compared to WT APCs that 
can phagocytose and present SR antigen to effector T cells. To test this hypothesis, we 
already did in vitro and in vivo phagocytosis assays and our results demonstrated that 
both WT and TLR2/9 DKO macrophages and dendritic cells were able to phagocytose 
SR efficiently. Next we used an antigen presentation assay to examine the ability of both 
WT and TLR2/9 DKO APCs to present SR antigen to effector T cells. We used both 
HKSR and SR lysate in the antigen presentation assays. Using HKSR, we measured 
IL-17 production from CD4+ T cells to test their effector function. If APCs were not able 
to present SR to T cells, we will find low percentage of Th17 cells. In order to confirm 
the production of IL-17 is actually from antigen specific T cells, one control should be 
added to the experiment: coculturing naïve CD4+ T cells with APCs presenting SR 
antigen. Since naïve T cells are not antigen specific to SR, we expected to find no 
response from naive T cells.  
 
We also used SR lysate to check if TLRs2 and 9 affect other pathways other than 
phagocytosis that soluble antigens use to be internalized. Both APCs and T cells were 
cocultured together in the presence or absence of SR lysate then IL-17 production was 
measured from CD4+ T cells using intracellular cytokine staining. Since there is a 
possibility that PAMPs in the SR lysate can stimulate T cells directly to produce 
cytokines, one control should be added to the experiment: stimulation of CD4+ T cells 
isolated from lungs of mice exposed to SR for three weeks with SR lysate then determine 
the production of IL-17 from CD4+ T cells with intracellular cytokine staining. In both 
cases (using HKSR or SR lysate), the results demonstrated that both WT and 
TLR2/9 DKO APCs were able to present SR antigen efficiently to effector CD4+ T cells 
stimulating them to produce IL-17as effector cytokine for Th17 cells. However, 
TLR2/9 DKO T cells tend to produce less IL-17 than WT CD4 T cells which requires 
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further investigation. One experiment would be stimulation of WT or TLR2/9 DKO 
CD4+ T cells with anti-CD3 then measure production of IL-17 by intracellular staining. 
Consistently, we observe ~3-4% Th17 cells following antigen presentation assays; 
however, Th17 response following three weeks of SR exposure was ~15% in WT mice as 
shown in Chapter 2 Fig. 2-7. The discrepancy in the results could be attributed to 
differences in experimental setups. We determined Th17 response in the lungs of WT 
mice by using total lung cells then stimulated the cells with SR lysate. The total lung cells 
already had effector T cells with APCs e.g interstitial macrophages as an example of 
efficient antigen presenting cell. On the other hand, in the antigen presentation assay, we 
tried to mimic the in vivo environment by incubating splenic APCs with HKSR to 
phagocytose, process, and present SR antigen then coculture them with T cells isolated 
from lungs. The splenic APCs could be less efficient in antigen presentation since they 
are not pure macrophages only. They are contaminated with other cells e.g. B cells which 
are less efficient antigen presenting cells. Another possible explanation is the ratio of 
APCs to T cells. We used a ratio of 1:1 in the antigen presentation assay. On the other 
side, the in vivo situation was different since the ratio of T cells to APCs might be lower 
than 1:1(i.e. 1:5, 1:10 or less). In one study, it was determined that the number of antigen-
MHC complexes required to stimulate effector T cells vs. naïve T cells. It was found that 
effector T cells require ~40 antigen-MHC complexes while naïve T cells require ~400 
antigen-MHC complexes [214]. To conclude, our studies demonstrated that both WT and 
TLR2/9 DKO BMDCs and BMDMs were equally efficient in phagocytosis of labeled 
SR. Furthermore, WT and TLR2/9 DKO splenic APCs were capable of SR antigen 
presentation and hence stimulation of the Th17 effector function (production of IL-17 
from Th17 cells).  
These studies led us to think about different alternatives to explain the original 
observation that following three weeks of SR exposure, TLR2/9 DKO mice were 
characterized by fewer Th17 cells in their lungs compared to their WT counterparts. DCs 
are crucial in initiating adaptive immune responses by polarizing naïve T cells in the 
lymph nodes. Our studies tested the phagocytosis ability of BMDCs, and we found that 
both WT and TLR2/9 DKO BMDCs were equally efficient in up taking labeled SR. We 
tried to examine expression of costimulatory molecules and cytokine expression from 
BMDCs; however, we faced a number of limitations as mentioned before. We 
hypothesized that TLR2/9 DKO BMDCs produce less IL-6 and TGF? (cytokines 
required for Th17 differentiation); consequently, they affect differentiation of naïve 
T cells to Th17 cells. Another possibility is that differentiation of Th17 cells is equally 
efficient in both WT and TLR2/9 DKO lymph nodes, but there is a defect in the 
chemokines required for migration of effector Th17 cells from lymph node to the lung.  
TLRs 2 and 9 and MyD88 Affect Cytokine Expression by BMDMs 
As mentioned before in chapter one, the cross-talk between the cells within the 
granuloma regulate the microenvironment. The cytokines produced by macrophages in 
the lungs might play a role in regulating effector T cells as well as the cytokine 
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environment in the granuloma. Following in vitro SR stimulation, we found a significant 
decrease in IL-6 production from TLR2/9 DKO and MyD88 KO BMDMs compared to 
WT BMDMs. IL-6 is a proinflammatory cytokine and it is required for Th17 
differentiation. IL-6 can also regulate T cell proliferation [215]. IL-6 KO ova specific T 
cells were not able to proliferate [215]. Since we already showed that both WT and 
TLR2/9 DKO BMDMs were equally efficient in phagocytosis and antigen presentation, 
we could hypothesize that the deficiency of IL-6 in the lungs of TLR2/9 DKO might 
affect proliferation of SR antigen specific Th17 cells; however, further experiments need 
to be done before making this conclusion. We hypothesized that expression of IL-10 from 
BMDMs will affect the expression of IL-17 expression from Th17. It has been shown 
that IL-10 down regulates IL-17 expression from CD4+ T cells [216]; however, we found 
a downregulation in IL-10 from TLR2/9 DKO BMDMs. IL-10 could be expressed by 
other cell types in the lungs. Both IL-12p70 and IFN? cytokines could play a role in the 
conversion of Th17 to Th1 cells [171]. Therefore, we might suggest that both cytokines 
are responsible for decrease in the Th17 effector cells in the lungs of TLR2/9 DKO mice. 
IL-23 is a survival factor for Th17 cells and we didn’t detect it from BMDMs. It might be 
another cell population is producing it. We already detect IL-23p19 message from the 
lungs of exposed mice following three weeks of SR exposure. As discussed earlier, 
TNF? plays an important role in the maintenance granuloma integrity. The significant 
decrease in TNF? from TLR2/9 DKO BMDMs might explain the dampened the 
inflammatory environment in the lungs of TLR2/9 DKO mice. Also, it has been reported 
that TNF?, IL-16, and IL-17A stimulates chemokines required for migration of Th17 
cells from endometriotic stromal cells [217]. Consequently, TNF? could play an indirect 
role in recruitment of Th17 cells into the lungs through induction of chemokines required 
for Th17 cells attraction. In conclusion, these results indicated TLRs 2 and 9 play an 
important role in the induction of these cytokines from BMDMs.  
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CHAPTER 5.   DISCUSSION 
 
 
HP IS ASSOCIATED WITH A PREDOMINANT TH17 RESPONSE 
 
The results from our studies demonstrated that granulomatous HP was associated 
with a Th17 response. Following three weeks of SR exposure (granulomatous HP), we 
found a predominant Th17 response associated with granuloma formation. Since we 
found Th17 response was predominant during granulomatous HP, we decided to examine 
T cell response during chronic HP. Following twenty five weeks of SR exposure, we 
found a strong Th17 response. In conclusion our results revealed that both granulomatous 
and chronic HP were associated with Th7 response. 
 
Although the results demonstrated that HP was associated with Th17 response, 
the studies were only showing a correlation between HP and Th17 response not a cause 
and effect relationship. To address the role of Th17 cells in HP, we could adoptively 
transfer Th17 cells into RAG-2 KO mice then expose the mice to SR for three weeks. 
Finally, we will measure parameters of disease severity such as granuloma formation and 
fibrosis. Simonian et al., also reported that HP is associated with Th17 response and they 
are required for lung inflammation and fibrosis. 
CORRELATION BETWEEN T-BET, DISEASE SEVERITY AND TH17 
RESPONSE DURING HP 
 
Despite the fact that Th17 was the dominant response during HP, there were a 
small percentage of SR specific Th1 cells in the lungs. However, we were not sure what 
is the role of these cells during HP? In our lab, previous studies showed that IFN? 
produced from Th1 cells was not necessary for granuloma formation calling into the role 
of Th1 cells. To address the role of Th1 in HP we used T-bet KO mice. Following 3 
weeks of SR exposure, we found upregulation in IL-17 mRNA and protein expression in 
T-bet KO exposed mice compared to WT exposed mice. Also we found an increase in the 
frequency of Th17 cells accompanied by exacerbated peribronchiolar granulomatous 
inflammation in T-bet KO exposed mice compared to WT exposed mice. Our findings 
were confirmed by other studies in the literature. For example, T-bet KO mice infected 
with SEA/CFA showed increase in disease severity accompanied by increase in Th17 
cytokines [169]. Furthermore, in T. cruzi mouse infection model there was an increase in 
the percentage of Th17 cells from the spleens of T-bet KO mice [170]. In conclusion, our 
studies revealed the protective role of T-bet during HP and its inhibitory effect on Th17 
response. 
 
Despite the protective role of T-bet and its inhibitory effect on Th17 response 
during HP, we did not address the type of the immune cell expressing T-bet that is 
responsible for these effects. To fulfill this aim, we could adoptively transfer either WT 
or T-bet KO naïve CD4+ T cells into RAG-2 KO mice then expose the mice for three 
weeks and measure parameters for disease severity and Th17 response. If we do see the 
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same degree of disease severity in both groups, therefore, T-bet in T cells is not 
responsible for disease severity. If we find disease severity in the group receiving T-bet 
KO T cells is more than mice receiving WT T cells, therefore, T-bet regulate disease 
severity in a T cell intrinisic manner. In T. cruzi mouse infection model, T-bet regulates 
Th17 development in T cell intrinisic manner. The authors showed the adoptive transfer 
of naïve T-bet KO CD4+ T cells into RAG-2 KO enhance expression of IL-17 from CD4+ 
T cells more than WT transfer to RAG-2 KO mice [170].  
 
 
EFFECT OF TLRS 2 AND 9 ON TH17 RESPONSE DURING HP 
 
The results from the previous two sections revealed that HP was associated with a 
predominant Th17 response and T-bet controls Th17 response and disease severity during 
HP. Consequently, we were looking for other factors that could regulate Th17 response 
during HP and we came across the following observation from previous studies in our 
lab. Following three weeks of SR exposure, the frequency of Th17 cells was fewer in the 
lungs of TLR2/9 DKO mice compared to WT mice. We were investigating the reason 
behind this observation and we found several possibilities that can be hypothesized. We 
tested one possibility which was inability of antigen presenting cells (APCs) to present 
SR antigen to effector T cell in the lungs of TLR2/9DKO. Since antigen presentation 
starts with the uptake of the bacteria, we tested first the phagocytosis ability of WT and 
TLR2/9 DKO APCs in vitro and in vivo. Our results revealed that both WT and TLR2/9 
DKO BMDMs or BMDCs were capable of SR uptake in vitro. To confirm the in vitro 
studies, we performed in vivo phagocytosis to test the phagocytosis ability of alveolar 
macrophages using labeled SR. The data have demonstrated that both WT and TLR2/9 
DKO alveolar macrophages are equally efficient in phagocytosis. In conclusion these 
results showed that absence of TLRs 2 and 9 does not affect the phagocytosis ability of 
APCs. Next we examined the antigen presentation ability of WT and TLR2/9 DKO APCs 
to check if they were capable of presenting SR antigen to effector Th17 cells. We found 
that both WT and TLR2/9 DKO APCs were equally efficient in presenting SR antigen to 
WT and TLR2/9 DKO effector T cells. In summary, TLRs 2 and 9 did not have an effect 
on antigen presentation ability of the APCs.  
 
 
  
95 
CHAPTER 6.   CONCLUDING REMARKS 
HP is a T cell-mediated disease and several studies have shown the pathogenic 
role of T cells during HP. Consequently, our studies were focused mainly on determining 
the type of T cell response and unraveling some of the factors that might control T cell 
response during HP. Targeting these factors might be a potential future therapy for HP.  
An overall summary for our studies is depicted in Fig. 6-1. Once SR is inhaled, it 
stimulates lung immune and non-immune cells to produce cytokines and chemokines in 
MyD88-dependant fashion. CXCL1 and CXCL2 are chemokines required for neutrophil 
recruitment. Following the first wave of cytokines and chemokines, neutrophils were 
recruited into the airways. Neutrophils were considered as a crucial source of IFN?? 
which is required for granuloma formation in this model. Our studies demonstrated that 
neutrophils produce IFN? in an IL-12/IL-18, or IL-15/IL-18-dependant manner.  
 
Dendritic cells can sense SR in the airways by their dendrites. Consequently, they 
undergo a maturation process and migrate to lymph nodes, starting polarization of naïve 
T cells into effector T cells. We found that the predominant T cell response in the lungs 
during HP was a Th17 response with minimal Th1 response. We also found that T-bet 
regulates Th17 response as well as granuloma formation during HP. Therefore, we 
consider T-bet one of the factors that regulates Th17 response as well as granuloma 
formation and lung fibrosis. Based on these results, we might consider T-bet as a 
therapeutic target for HP treatment. Polymorphisms in T-bet could explain why some 
patients develop fibrosis while others do not. Sequencing T-bet from a number of HP 
patients at the chronic stages and comparing them to patients at granulomatous stages as 
well as normal subjects could give us insights into how T-bet polymorphisms decide the 
fate of HP. 
 
We also found from previous studies in our lab that TLRs control the Th17 
response during granulomatous HP; however, the mechanism(s) behind this control is 
still under investigation. So far we found that TLR2 and 9 did not affect the phagocytosis 
ability of macrophages and dendritic cells. Furthermore, TLRs2 and 9 did not affect the 
antigen presentation ability of APCs. Even though we still lack the exact mechanism of 
controlling Th17 response by TLR2 and 9, that doesn’t eliminate the idea of TLRs as 
therapeutic targets. Again TLRs polymorphisms could play a role in the severity of HP. 
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Figure 6-1. Overall HP model. 
SR stimulates AMs and probably other cells in the airways to produce different 
chemokines and cytokines that recruit neutrophils into airways. SR also could be detected 
by DCs which consequently migrate to lymph nodes to initiate polarization of naïve T 
cells into effector Th17 cells. Th17 effector T cells migrate to the lungs for granuloma 
formation. T-bet inhibited both Th17 development and granuloma formation. Both WT 
and TLR2/9 DKO APCs were able to present SR antigen to Th17 cells, stimulating IL-17 
production from Th17 cells. 
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